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I N T R O D U C T I O N 
The abundant and still increasing use of psychosedatives in clinical and 
general practice stimulated the investigation of the pharmacokinetics, 
chemical analysis and clinical pharmacy of some of the frequently used 
drugs in the relief of neurotic, anxious, aggressive or mentally strained 
patients. Because of their central muscle relaxing and anticonvulsive 
properties these drugs are also used in surgical premedication and in the 
clinical treatment of epilepsy. 
The simultaneous introduction of many modern types of psychotropic 
drugs in the early fifties promoted the research to drug design, thera­
peutic application and metabolism of new compounds. Aleprobamate 
was the first compound of a new group of psychosedatives to replenish 
the classical barbiturates, bromides, bromcarbamides and chloral deriv­
atives. This group is distinguished of the group of the neuroleptics such 
as chlorpromazine, haloperidol etc., which are primary used in the 
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IO INTRODUCTION 
treatment of the more severe psychoses. The term ataractic is now 
reserved for the tranquillizers enclosing the subcategories of the mepro-
bamate-and diazepine-group ( F I G . I ) . In addition some barbiturates and 
non barbiturates : scopolamine and diphenylmethane-derivatives (hy­
droxyzine) exhibit ataractic properties. The ataractics have a calming 
effect at doses that do not yet produce sedation or drawsincss. Λ further 
characteristic is their antianxiety effect in animal and man. 
The purpose of this investigation was to study kinetics of distribution, 
elimination and metabolism of the main representatives of the ataractics. 
On the basis of differences in physicochemical properties of the ataractic 
compounds variations in kinetics of distribution were anticipated. 
Kinetics of ataractic drugs in man can only be derived from plasma 
concentration data, since hardly any drug is excreted in the urine. 
The complexity of the relations between drug concentrations in plasma 
and at possible sites of action promoted the distribution studies in mice. 
Whole body autoradiography was chosen because of the advantages to 
detect regional presence of drugs. In addition of pharmacochemical 
separation techniques the contribution of the metabolic processes could 
be followed. The uniformity of a population of mice enabled a greater 
reproducibility than in greater animals. 
For the accurate estimation of pharmacokinetic parameters specific and 
sensitive analysis techniques and many concentration data are necessary. 
Frequent sampling of blood is practically not feasible in man. For a more 
accurate determination of the fate of the drugs in the living body the dog 
was chosen to estimate the concentration-time course with radio-tracer 
methods. 
In general, protein binding is considered as an important factor in 
elimination and distribution of drugs. Protein-binding capacity was 
studied both "in vivo" and "ш vitro", in dog and man. 
From literature some data were available on the fate of diazepam in 
man. However, the reported kinetic values differed. Considerably a 
half-life of about 30 h will give rise to accumulation during chronic 
treatment. Diazepam and its major metabolite were simultaneously 
investigated in plasma after a single dose and during chronic treatment 
on a fixed dosage regimen. 
CHAPTER I 
PHARMACOKINETICS 
INTRODUCTION 
The study of "pharmacokinetics" includes the investigation of proces-
ses involved in concentration-time relationships of drugs in human and 
animal bodies (DOST, 1968; KRÜGER-THIEMER, 1968). 
When a drug is introduced into the body, many rate-dependent proces-
ses can take place before drug molecules and receptors interact and the 
principle aim of the administration : the therapeutic effect, is reached. 
Only in a few cases the compartment into which the drug is administered 
is equal to the biophase or, in other words, the compartment of action, 
such as for instance for plasma expanders. 
The biological object can be considered as a multicompartment system. 
A compartment is defined here as a mathematical entity, which can have 
biological similarities. The distribution of a drug over a complex multi-
compartment system is determined by various transport functions for 
directly related compartments. 
The term compartment is not restricted here to the anatomically and 
physiologically well defined and imaginable body fluid and tissue com-
partments, such as intra- and extracellular fluid. Also proteins and other 
constituents of the biological object, able to bind drug molecules, can be 
referred to compartments since their interaction with drug can be inter-
preted by mathematical expressions. 
FATE OF DRUGS IN THE TOTAL BODY 
After administration of a dose О A0 of a drug into the body, the fate of 
this drug can be represented by the scheme in Fig. 1. This scheme is a 
very simplified expression of the complex sequence of processes taking 
place in the living body. 
What is indicated by one compartment, one line, one rate parameter 
might at closer view be dissected into many compartments, lines, etc. 
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The reaction of drug molecules with receptors is mainly considered as 
an equilibrium reaction and can be expressed mathematically by the 
mass-action law and the Langmuir adsorption isotherm (ARIENS et al., 
1964). 
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Schematic representation of the kinetic processes considered in this study. T h e dose 
Ол" is introduced into the absorption site compartment (o) from which rate depending 
processes influence the exchange with the central compartment (1) where &01 — absorption 
rate constant. kla can be considered when enteral circulation takes place Elimination 
of drugs from the central compartment is possible by a) excretion to the infinite volume 3, 
6) by exchange with compartment (2), c) by metabolism (compartment M) and d) by 
protein binding. Although much more refinements can be made and more compartments 
can be introduced which complicate the mathematical treatment, drug concentration-time 
data can often be interpreted in one or two compartment kinetics. The protein binding 
capacity can be represented by an association constant according to the mass-action law. 
Metabolism can be treated as a separate compartment since the rate of metabolite ap­
pearance in the compartment of analysis can also be interpreted as a first order process. 
Drug receptor interaction is not studied. 
Many factors in the living organism mediate this drug-receptor 
interaction ; there is a "dynamic equilibrium". These factors play a role 
in the appearance and disappearance of a substance or in the words of 
DOST (1968) : "in the disturbance and recovery of the dynamic equili­
brium". Therefore factors such as diffusion, passive transport, filtration, 
local distribution, adsorption, chemical reaction, rough mechanical 
convexión influence, alone or combined, the kinetic processes of dis-
tribution of either a physiological or pharmacological compound. 
In principle all these processes can separately be considered in mathe-
matical terms. Some processes may dominate the observed phenomena 
while others can be neglected. It is therefore often allowed to summarize 
the experimental data of the drugs in the body in simple terms. 
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PRESENCE OF COMPARTMENTS 
Most drugs, except the intravascularly administered ones, are mainly 
absorbed by passive diffusion across membranes which function as lipid 
barriers. 
The characteristics of the membranes, which are considered as semi-
permeable, vary from organ to organ and from tissue to tissue, even 
within subcellular constituents. One may say that the characteristics of 
the membranes differ from compartment to compartment. The passage 
of drugs through membranes can be expressed by rate constants. Thus, 
anatomically distinguished body constituents may have mathematical 
resemblances. 
It is known that substances with low lipid, water partition coefficients 
usually show poor membrane penetration, whereas lipophilic substances 
with corresponding high lipid/water partition coefficients usually show 
fast and efficient passage (BUTLER, 1950). Exceptions to this rule are the 
low molecular weight lipid-insoluble substances, such as urea and water. 
Body membranes may be viewed as lipoid barriers periodically inter-
rupted by small water-filled channels or pores (DOLUISIO and SWINTOSKY, 
i n -
certain barriers, such as those existing between blood and brain, will 
allow the passage of only highly lipid-soluble substances, while other 
membranes, such as those existing between blood capillaries and the 
extracellular space are porous and allow the passage of certain macro-
molecules. 
TRANSPORT OF DRUGS 
T O reach the so-called biophase or receptor compartment, the drug 
molecules are designated on an available transport medium or, in the 
simplest case, on free diffusion from the dosage compartment through 
various other compartments (FiG. 1). 
The transport can be distinguished in : 1. passive transport, 2. active 
transport, 3. special mechanisms, 4. transport by body fluids. 
1. As far as the distribution over the multicompartment system is 
based on free diffusion of the drugs, the overall physicochemical proper-
ties such as hydrophility, lipophility, ionic character, polarity, size and 
shape are determinant factors (ARIENS, 19681). 
2. Active transport of drugs is often qualified as such by the need of 
energy, supplied by metabolic, enzymatic processes. One may distinguish 
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free diffusion and carrier-bound diffusion. In the case of free diffusion 
Pick's law can be applied and here, in principle, a straight proportionality 
between diffusion velocity and concentration gradient is observed. There 
is no preference in direction. In the carrier-bound diffusion one step in 
the biological sequence of the system can be a rate-limiting factor. 
Saturation of the carrier system and a maximum in the transport velocity 
can occur. The system is, in general, specific for certain compounds. 
Phenomena of competition for the carrier system are observed. Mainly a 
preferred direction in the membranes and transport against a concentra-
tion gradient can be distinguished (ARIËNS, 19682). 
3. Uptake of substances in the cell by phagocytosis and pinocytosis 
and the release by reversed pinocytosis are phenomena reported to 
histological observations. In this case no membranes are directly involved 
(LASTER and INGELFINGER, 1961). 
4. Drugs can be transported from the site of absorption through the 
body by blood, lymph or cerebrospinal fluid. Compounds in blood can be 
transported either dissolved in the water fraction and when bound, by 
the protein fraction. Water-insoluble, lipophilic compounds are mainly 
protein-bound (see Chapter 2). There is an apparent correlation between 
lipid/water partition coefficients and protein binding within a series of 
compounds (GOLDBAUM and SMITH, 1954; DOUGLAS et al, 1964; VAN DER 
KLEIJN, 1969). 
Intravascularly administered, at the physiological pH insoluble drugs 
are frequently introduced into the body as highly concentrated and 
solubilized liquids or even in crystalline form. At least, when introduced 
into the body in a small volume many drugs might crystallize in the area 
of administration at the pH of the body fluid. Proteins will restrict 
crystal growth. While the concentration decreases plasma proteins behave 
as stabilizers or solubilizers for the saturated solution. 
The term protein binding should be reserved to those phenomena in 
which the interaction between drug molecules and proteins can be ex-
pressed according to the mass-action law, in other words, when one can 
distinguish at least mathematically one or more classes of binding sites on 
the receptive molecule. The degree of protein binding is concentration 
dependent in the sense that the protein-binding capacity is high at low 
drug concentration. In the case of solubilizing, phenomena other than 
those involved in protein binding will play a role (Chapter 2). When no 
concentration dependence can be observed, physicochemical partition 
between aqueous and micellar phase must be considered. 
PHARMACOKINETICS IS 
RELATIONS BETWEEN DRUG CONCENTRATIONS IN 
BODY COMPARTMENTS AND BIOLOGICAL ACTIVITY 
Since the very beginning of drug therapy the relationship between the 
dose and its activity has been well-understood. T h e study of concentra-
tion-activity relationships, which is called "pharmacodynamics" , has only 
with few exceptions been integrated into pharmacokinetics. Relationships 
between concentrations and activity in living individuals is often intricate. 
In general after a single dose the maximum blood level of the drug docs 
not coincide with the maximum tissue levels, nor the t ime of maximum 
biological activity. Theoret ical predicting of concentrat ion-t ime relation-
ships of drugs in various body compar tments by a kinetic approach does 
not necessarily delineate the pharmacological activity-time relationships 
( L E V Y , 1964, 1966, 19672; VAN ROSSUM and VAN K O P P E N , 1968; SEGRE, 
1967; N E L S O N , 1961; M A I C K E L et al., 1969). 
Nevertheless, the therapeutic activity of a drug is considered to be 
controlled by its concentration at the site of action, in the biophase or the 
receptor compar tment . Th i s concentration is assumed to be closely 
related to the concentrations in the other compar tments , one of them 
being the blood. 
Many fundamental studies have been made on the relation between 
concentration and activity in isolated systems (ARIËNS, S I M O N I S and VAN 
ROSSUM, 1964). 
By plott ing the intensity of a well defined effect against the applied dose 
similar curves of several drugs are obtained. In general the effect will 
asymptotically reach a max imum value. Increasing the dose when the 
maximum effect is reached will not result in a greater effect. Over a 
restricted concentration range the increase in the effect is directly propor-
tional to the logarithm of the dose. However, in an individual it has often 
been impossible to choose the right criteria and circumstances to demon-
strate such a reproducible concentration-activity relationship. 
K I N E T I C S OF ELIMINATION 
In this s tudy mainly first-order kinetics are considered. In many cases 
the concentrat ion-t ime course of drugs in plasma appears to decrease 
rapidly at first and thereafter more slowly as the amount in the body 
declines. T h e rate of disappearance is directly proport ional to the con-
centration at each moment . 
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This means that 
dQAjdt = -kCÁ (1) 
where : 0A = amount of drug A present in the body (mg or mole), 
k — clearance rate constant (1/h, ml/min) and CA = concentration of the 
drug (mg/l, μg¡ml, M). 
С A is equal to the amount of drug (QA) divided by the volume (V) of 
the compartment over which it is uniformly distributed. 
Integration of equation (i) leads to the exponential expression 
С
л
°ег*І* (2) 
where : С
А
' — concentration of drug A in plasma at time t, CA
0
 = con­
centration of drug A initially present, and τ = the time constant for 
elimination. 
Vik (3) 
A theoretical concentration-time curve is graphically represented in 
Fig. 2A. According to equation (2), a straight line is obtained when the 
logarithms of the drug concentration are plotted against the time ( F I G . 
2B). 
The time constant is the important parameter of the disappearance 
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A. Exponential decline of the plasmaconcentration represented in a linear diagram 
according to the scheme of a one-compartment open system. 
B. The logarithm of the plasmaconcentration declines according to a straight line. 
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process, τ is directly related with the biological half-life time (ij) ac­
cording to : 
tl = 0.693 Χ τ or τ = 1.44 χ 11 (4) 
The drug concentration can analytically be determined at any desired 
time, so that t^ and τ can easily be calculated from the log concentration-
time curve. 
CA0 can be found with sufficient accuracy as the intercept of the curve 
with the ordinate of the log concentration-time line. 
This presentation will only fit experimental data when the achievement 
of the equilibrium situation is rapid compared to the disappearance or 
elimination process. This is often the case after intravenous adminis-
stration or when the absorption is very rapid compared to the elimination 
process. 
¿2 and τ do not give information about the mechanism of drug disap­
pearance. Since τ = F/A the disappearance can be controlled either by 
the clearance rate constant, by the distribution volume or by both. The 
distribution volume and the clearance rate constant are therefore very 
important parameters in pharmacokinetics. 
T H E F I C T I V E D I S T R I B U T I O N V O L U M E 
The fictive distribution volume is for more reasons an important 
factor in pharmacokinetics since it has been shown that its value is nearly 
constant irrespective of the applied dose as soon as the dynamic steady 
state is reached (DOST, 1968). 
In the simple case of exponential elimination of the drug V can be 
found from : 
V = QJC/ (5) 
The distribution volume may have physiological resemblance. When 
the drug is uniformly distributed over for instance the total body water or 
the extracellular space, plasma concentrations might reflect a physiolo­
gically distinguished body fluid compartment. 
Distribution studies of drugs with the whole body autoradiographic 
technique, often demonstrate an unequal distribution (ULLBERG, 1958). 
In general, however, the value for V has no physiological or anatomical 
resemblance. 
Since several tissues show different affinities for the drug and specific 
variations in exchange rate will govern the distribution process, it is 
2 
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better to introduce the term fictive or apparent distribution volume (V/). 
Vf can be considered according to the following relation : 
Vf =v1[i+ ( V vjHkni v2) -f · · • + (k1Ni vjUKil ^ ) ] (6) 
where Vf = fictive distribution volume, V^^ = plasma volume, V^ = 
fictive volume of a peripheral compartment and VN — fictive volume of 
compartment ΛΓ. 
When the value of Vf is known, information becomes available about 
the mechanism of drug elimination and clearance (RIEGELMAN et al., 
i9682). 
The distribution volume is predominantly controlled by the phy-
sicochemical properties of the compound and the receiving tissue 
(RIEGELMAN et al.. 19681). For one drug individual variations can be 
expected. 
Generally the pharmacological influence of the drug on the physiolo­
gical conditions of distribution and elimination is neglected. In some 
cases the action of the drug (e.g. diuretics) changes the distribution or 
elimination processes. It appears that the amount of drug in the various 
tissues and compartments can differ greatly from that in the blood, while 
in other tissues the amount may be equal at the same time. 
The distribution volume is an important factor to estimate optimal 
dosage regimens of patients. A common method derives the parameters 
necessary for calculation from plasma concentration data after adminis-
stration of a single dose (HUNGER et al., 1961 ; WAGNER, 1969). However, 
it is possible that no steady state will be achieved after a single dose 
(DE SILVA et al., 1966). It is more reasonable to estimate drug levels after 
repeated dosage and to determine the rate of accumulation (VAN ROSSUM 
and TOMEY, 1968; Chapter 7). Regular estimations of plasma concentra­
tions enable the detection of over-, under- or correct dosage regimens. 
If necessary correction can then be made during chronic treatment. 
When the drug in the central compartment rapidly and extensively 
exchanges with a small, but for drug action or distribution highly 
specific peripheral compartment, oscillations of drug concentrations in 
this compartment will seldom be recognized in the central compartment. 
Since k1N¡kNl is high, variations in drug concentrations will have great 
influences in the small peripheral compartment. The clearance ratio is 
often unknown, so blood concentrations will give no information about 
the concentration in the specific peripheral compartment. 
Analysis of concentrations in tissues and organ homogenates where the 
site of action is supposed to be located is also often insufficient to detect 
the presence of the drug in a small specific compartment or biophase. 
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The difficulties involved in the correlation of the amount of drug 
in the plasma with the amounts in other compartments lead to the selec­
tion of macroautoradiography in intact animals as a tool to distinguish the 
drug at regions which are impossible to follow in living animals or men. 
In this section disappearance of the drug is considered according to a 
monophasic exponential elimination which assumes the instantaneous 
and uniform presence of the drug. At least absorption is so rapid that 
no influence on the elimination process can be demonstrated. 
Many factors, however, can influence the establishment of the dyna­
mic equilibrium situation. The rapidly injected fluid will be mixed over 
the total plasma volume which will take about 5-15 minutes before a 
steady state is reached. At the same time exchanges with the extra­
cellular, intracellular and other possible compartments may occur. The 
rate of this exchange is determined predominantly by the physicochemi-
cal properties of the drug. There are also physiological factors influen­
cing the slope of this first part of the concentration-time curve. These 
factors can be mediated by the drug, by the reaction of the body to the 
injection, the viscosity of the administered substance, the state of vessels 
and capillaries, the vascularity of the tissues, etc. When the initial equi­
libration period shows its influence on the second phase of the curve a 
two- or multicompartment system can be considered (ROWLAND and 
RIEGKLMAN, 1968; this chapter, page 17). Multi-exponential equations are 
necessary to interpret the concentration-time course. 
KINETICS OF ABSORPTION 
In pages 13 and 14 factors are discussed concerning the direct adminis­
tration of drugs into the blood circulation. All other routes of administra­
tion will take time before the transport medium is reached. 
The extent and the rate of absorption are of great importance to drug 
action. They determine the magnitudes of plasma and tissue concentra­
tion with respect to time and hence, the onset, intensity and time course 
of biological activity. Many factors influence the rate and the extent of 
the passage of drugs from the absorption site compartment to the body 
fluids. The several routes to administer drugs will not be discussed. 
Absorption of drugs may be considered as a first-order process. Under 
the assumption that the drug is not eliminated the following equation is 
derived, representing the concentration in the body (CV) as a function of 
time (t) : 
<v = (evra i - «-"ч (7) 
where : ^ =• time constant of absorption. 
2 0 E. VAN DER KLEIJN 
In this model the plasma concentration increases to a maximum level 
when complete absorption is reached. 
When simultaneous exponential elimination of the drug takes place in 
addition to the first-order absorption process and no elimination by 
excretion occurs, the elimination term can be included. 
e
- "
T i ) (8) 
where : т2 = time constant of elimination. 
From Fig. 3 it may be clear that the intercept of the extension of the 
elimination curve with the ordinate, M, 
M=(QA0¡Vf).[r2l(ri-r1)] 
10" 
V 0 = 5 1 
k 0 1 = 1 0 1 / h 
T 1 = 0 . 5 0 h 
m =9.1 10" 5 м 
Q^=3.1Cr3mol 
Vi = 3 6 1 
k 1 3 = 6 1 / h 
T2 = 6 . 0 0 h 
t i =4.16 h 
et (bí 
FIG. з 
Curve representing the logarithm of the plasmaconccntration after oral administration 
i\hen absorption and elimination simultaneously take place according to first-order 
processes. The intercept of the extension of the elimination curve with the ordinate 
gives M 
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cannot simply be treated as the fictive initial drug concentrat ion С Д 
t h u s allowing the calculation of the distribution volume (equation 6) 
since : 
C / = M ( T 2 - T J / T , (9) 
W h e n т1 is small compared to τ 2 , M is equal to CA
0
 and the data can be 
interpreted in a one c o m p a r t m e n t system. T h e course of the concen­
tration is represented in Fig. 3. 
When the drug is t ransported to the absorption site compar tment , 
which is probable when enteral circulation occurs, the plasma concen­
trat ion follows a second-order process. 
K I N E T I C S OF DISSOLUTION 
I n many cases drugs are administered as active substances mixed with 
inactive additives. Wherever the place of application will be, the rate of 
release of the active c o m p o u n d s from the additives or, when no additives 
are used, from the dosage must be considered. Since the release can be 
expressed in mathematical te rms we will consider the dissolution of the 
drug and its influence on the absorption site c o m p a r t m e n t as a specific 
c o m p a r t m e n t : the drug dosage compartment . 
T h e equation originally introduced by N O Y E S and W H I T N E Y in 1897 
for benzoic acid generally covers the phenomena affecting the dissolution 
of drugs : 
С
А
' = С Л І - e-"*D) (10) 
where : тд = t ime constant of dissolution (h, min), CV = concentrat ion 
of saturated solution of the drug (mg/ml, g/l, M), and C / = concentra­
tion of the solution at t ime t (mg/ml, g/l, M). 
T h e experimental work of N E L S O N (1957) has led to the following 
equation for the dissolution of drugs : 
QA* = KSCJ (11) 
where : QA' = the a m o u n t dissolved, К = the rate constant with 
dimensions distance/time, S — the surface area and C
s
 = the concen­
tration of dissolving solid at the solid side of the diffusion layer. 
К is controlled by physical state of formulation, particle size, crystal 
shape and solubilization tendency of the particle surface influenced by 
secondary forces, intensity of agitation, temperature, etc. T h e absorption 
equation (7) can be read as : 
CA> = KSCst(l-e-"^)¡Vf (12) 
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However, factors other than dissolution rate are involved in the availa­
bility of drug molecules for absorption. They can be either physical or 
physiological. 
Chemical stability in the physiological environment, chemical modifi­
cation by complex formation or conversion influenced by the environ­
ment, pH and hence, the degree of ionization, and the partition coefficient 
are important physical factors in the absorption characteristics of the 
drugs. 
Physiologically, surface and motility (peristaltic activity) of the ab­
sorption area, vascularity and bloodflow rate, stomach emptying, which 
may be influenced by the drug itself or by the condition or the position of 
the patient, enteral circulation, and metabolizing micro-organisms at the 
site of absorption can have a retarding or accelerating influence on drug 
absorption (WAGNER, I96I ; LEVY, 1967 (1); RIEGELMAN et al., 1968 ( ι ) ; 
SCHEUNE, 1968). Rate of release from the dosage is important when 
sustained absorption is intended (WIEGAND and TAYLOR, i960; KRÜGER-
THIEMER and ERIKSEN, 1966). 
KINETICS OF METABOLISM 
When biotransformation is an important factor in the elimination of a 
drug and when the appearance and elimination of the metabolite(s) can 
also be treated as first order processes, the system can be interpreted 
according to Fig. 4A0. The following differential equation for the meta-
bolite(s) can be formulated : 
dQM¡dt =-- kìMCA1 — kM3CM (13) 
After integration the following equation is derived : 
CM1 = {QAWXKTMHTU, --r)][kM3;(kM3 + k13)]{e-'''T2" -*-" т) (И) 
where : k
m3 = clearance rate constant for metabolite (1/h), ^ 3 = clearan­
ce rate constant for parent drug (1/h), τ 2 Λ / = time constant of metabolite 
elimination. The time constant of elimination of parent drug (τ) — time 
constant of metabolite appearance (VAN ROSSUM, 19681). 
Since the fictive distribution volume is dependent of, among other 
factors, the physicochemical properties of the compound this value may 
differ for drug and metabolites. 
k13 will also be controlled by other physicochemical properties such 
as ^Â^-value, lipophilic nature and protein binding. Fig. 4A and В give 
two theoretical examples for cases when the clearance constants of the 
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drug and its metabolites are varied. Fig. 4C shows the theoretical case of 
the consequences of repeated administration, when the metabolite 
manifests a much slower elimination than the parent compound. Accu­
mulation of the metabolites takes place. 
ріа&гга concentration (mg/I ' 
рЪ та concentration (mg/1) -
Fro. 4 
4Aa — (insertion) Schematic representation of the kinetic processes involved in the 
elimination of a dose Q^0 by metabolism and excretion of drug and metabolite. 
4A — Log plasmaconcentration-time curves of drug A (Q^ 0 — io mg) and its meta­
bolite M when elimination is controlled by excretion (kl3 = 30 1/h) and by biotrans­
formation at a slower rate {klM — 6 1/h). Excretion of metabolites is relatively slow 
(*мз = 3 1/h). The fictive distribution volumes of, both, drug and metabolite are equal 
(Vi = VM - 36 1); ( n = r, i i = 0,69, т , и - 12 h). 
4B — Log plasmaconcentration curves of drug A and metabolite M under the same con­
ditions as in Figure 4A. Here the excretion clearance of the drug is slow (к
ІЯ
 — 6 1/h) 
and the metabolic clearance is high (кц^ = 30 1/h). The excretion of the metabolite is 
again slow {kM3 — 3 l.'h). 
4C — Log plasmaconcentration pattern of drug A and metabolite M under the same 
conditions as in Figure 4A after repeated dosage (4 d.d. io mg). As a consequence of 
the great time constant т
гМ
 of the metabolite, accumulation will occur while accumulation 
of the parent drug can be excluded. The maximum level of the metabolite reaches its 
maximum after about 30 h. The maximum plateau level is 2 i times higher than the 
maximum level after a single dose. 
The curve corresponding to the sum of the molar concentrations of the 
parent drug and the metabolite will be represented by : 
C,' = CA' + CM* (15) 
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Depending on the chosen parameters this curve has much in common 
with the curve of total radioactivity found in the experiments on the 
meprobamate-group (Chapter 6). 
PROTEIN BINDING 
There is sufficient evidence that it is not the concentration of a drug in 
the plasma, but the concentration in the plasma water : the unbound, 
so-called free drug concentration that is of direct importance for the 
exchange with the tissues and for elimination (KRÜGER-THIEMER et al., 
1964; KRÜGER-THIEMER, 1968). Many drugs, organic as well as inorganic, 
can bind to proteins. From the therapeutic point of view plasma proteins 
can function as a depot. 
CAf , the free plasma concentration of a drug controls the concentration 
gradient, when transport to other compartments is achieved by free 
diffusion. 
The fictive distribution volume (F /) must be calculated on the basis of 
CAJ '• 
V, = QJICA, (16) 
Protein-binding capacity is concentration dependent for many drugs. 
The capacity will decrease at higher concentrations when primary 
classes of binding sites are saturated. 
When drug-protein interaction can be described according to the mass-
action law the relation between free drug concentration and the total 
plasma concentration (Сл) reads : 
Сл, = \.{KAPCAI + \)¡{K/CA¡ + nK/Pt + 1)] CA (17) 
where : KAP = association constant, P , = total concentration of protein 
with binding capacity and я = number of independent binding places. 
In the field of ataractic drugs of the meprobamate- and diazepine-
group no concentration dependence could be demonstrated in physio­
logical circumstances over the therapeutically possible concentration 
range. Here the fictive distribution volume on the basis of СΆ/ will be 
found by multiplying CA with a simple factor (Chapter 2). 
Vf = (100/% unboundXÖ^/C^) (18) 
ACCUMULATION 
When drugs are chronically administered to patients, which is very 
often the case in, for instance, chemotherapy, cardiology, endocrinology 
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and in psychiatric practice, accumulation has to be considered. Theo­
retically accumulation will occur when drug administration is repeated 
before the previous dose is eliminated ( F I G . 5). 
C A ( Ю - 4 M ! , 
F I G . 5 
Log concentration-time curve of a drug after repeated dosage at intervals (Δ t) much 
shorter than the biological half-life (ij) of elimination. Accumulation till a maximum level 
takes place. 
In many cases a continuous effect of the drug is desired and dosage 
schedules are designed by trial and error to enable the adjustment of a 
constant therapeutically effective drug concentration level and response. 
It will be evident that this level will oscillate around a mean level depend­
ing on dose, route of administration, dosage interval, biological half-life 
time of elimination, dosage form, simultaneous drug supply, etc. 
A single dosage may often be insufficient for the achievement of the 
steady state and thus for reaching the constant individual value for Vf. 
The rate of accumulation depends merely on the half-life of elimination. 
The mean plateau plasma concentration of a drug A {CAPI) can be 
represented by a simple formula assuming the operation of first-order 
kinetics and complete absorption : 
£ ы = l-44(CV/FM)(í^/J0 (19) 
and for metabolites (M) : 
CMvl=\AA{0A*¡VmmM>At) (20) 
(WAGNER, et al., 1965; VAN ROSSUM and TOMEY, 1968). 
When dosage is repeated at fixed periods equal to the half-life time of 
elimination ( Δ * = '?)> it has been calculated that : 
taci = m + 3.3.l0g Т2/(Т2 - Tj)] (21) 
where : t
ac
\ — time of reaching 50 % of the plateau level, τ
ι
 = time 
constant of absorption, τ 2 = time constant of elimination (VAN ROSSUM, 
19682). Drugs with a long half-life of elimination show the strongest 
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accumulation capacity. In those cases т2^>т1 and, hence tni.\ — t\. This 
means that after a period of 3 times t„,.% 87.5 %, after 4 times more than 
93 % and after 5 times more than 96 % of the mean accumulation plateau 
level is reached. Fig. 4C shows an example of the case for a metabolite 
with a different t\ than the parent drug. Thus while the parent drug does 
not accumulate, the metabolite reaches a plateau level. 
MULTICOMPARTMENT SYSTEM 
In many cases it appears that a one-compartment system is a too 
simple approximation of the phenomena which take place after intro­
duction of a drug into the body. When many analytical data are collected 
the logarithmic plasma concentration curve may show a bi- or multi­
phasic pattern. This curve can be interpreted by assuming the distribu­
tion of the drug over more than one distribution volume (ROWLAND and 
RlEGELMAN, 1968) . 
Biphasic, exponentially declining plasma curves can be interpreted in 
terms of a two-compartment open system as represented in Fig. 6Aa. 
When a drug is introduced without delay into the central compartment 
(1), then at time о the amount of drug in the body is equal to the dose 
QA0- Exchange with the second or peripheral compartment takes place. 
The exchange processes may be presented by a series of linear differential 
equations : 
dQjiidt -kiiCA1 — k^C^ — kuCAl (22) 
dQA2ldt = knCAl - k.nCA2 (23) 
аОляіаі kl3CA3 (24) 
where : k12, k21, k13 are the clearance rate constants (ml/min ; 1/h) and 
QAl, 0A2, 0A3, are the amounts of drug in the central and peripheral com­
partment and the amount excreted. 
After integration the following equations are obtained for the con­
centration of the drug in the central compartment (CAl), the quantity in 
the peripheral compartment QA2 and the quantity eliminated 0A3 : 
CAX =_ L i e-' '
T
' + L*1·-"· (25) 
QA* = MVle-^ -
 e
- " 4 (26) 
QA3 - QA* - Л -" Т 1 - JV-"T" (27) 
in these relations : 
1 / т л - = ( * ! , / ^ X V ^ · ) (28) 
1 /14 + 1 /τ, - V V1 + Au/ Vi - kj V2 (29) 
PHARMACOKINETICS 27 
From the experimental curves it is possible to estimate directly τ 2 and 
L 2 ( F I G . 6A). The residues of the extension of the second phase from the 
CAI(M) — 
q4 -edi 
|kw 
Ti = 04O2h T2 = 5 6 0 S h t i = 478h 
1^=197 10"SM L2=07Z 10"
5
м 
01= 3 10"4mol 
0 1 2 
(quantity moles 1СГ4) 
3 
F I G . 6 
6Aa — Schematic representation of a two compartment open system. 
6A — Log concentration-time curve of a drug after a single dose (Ол 0). From the course 
of the second phase of the curve, т2 and L2 can be found. T h e residue of the extension 
of this phase from the total curve gives another straight line from which τ, and 1^ can 
be found. 
6B — T h e data in A allow the calculation of the course of the amount of drug in 
the peripheral compartment (QAI) and of the excreted amount (О^з). 
6 C — When the clearance ratio is known it is possible to calculate the fictive distri­
bution volume of the peripheral compartment (V2) and the course of the concentration 
CU2. (V, = 12 1; V2 = 24 1; k. 16 1/h; * „ - 12 1/h). 
total biphasic curve give a new line from which т1 and Lj can be cal­
culated. These data allow the calculation of V1, kl2, k13, k21¡V2 and hence, 
М
 г
 and A'j and ЛГ2 according to the following equations : 
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V, -QSKLi+LJ (30) 
*» = QA'LAHT, - TJVML, + L2f ( т ^ -f r2L2)] (31) 
*i3=ß-i e /(T1L1-rT2L t) (32) 
Ä21/ F2 = ( T A + T2/.2)/r1r2(L1 + L2) (33) 
MV2 QAbnlk13) V2lk21(r2 - TJ (34) 
tfl = е Л ( »'«/Ли) - rj/tr, - Tj) (35) 
л
г
2 = ρ / [ τ , - (v2ikn)]i(4 - τ,) (36) 
7 , = Val+ikJVJKktJVJ] (37) 
From the dose QA0 and the obtained parameters TJ, T2, L J and Lg l t ls 
possible to calculate к^/ ^, k^jVz and к
іг
І
 г
. Also the amounts present 
in the peripheral compartment and the amount of the excreted drug can 
be calculated at any time ( F I G . 6B). 
Some times it is allowed to consider A12 = k2l, which simplifies equa­
tion 34 to equation 38. 
M = QA0íkl3{r2 - τ,) (38) 
and CA2 = M(e-"T* - e-"ri) (39) 
From equation 33 it is possible now to calculate a value for V2. Also the 
concentration-time course in the peripheral compartment can be cal­
culated ( F I G . 6C) with equation 39. 
However, for drugs that rapidly penetrate into the intracellular com­
partment which is the case for the ataractics in our study, the clearance 
ratio Ä^/^ai m a y be much greater than 1 and behaves as an apparent 
distribution coefficient. In this case it is not possible to calculate the 
values for V2 and to get information about the concentration course in 
this peripheral, tissue compartment. 
When more phases in the experimental concentration pattern of drugs 
can be observed more compartments must be taken into account. Highly 
complicated mathematical terms will be necessary to derive the para-
meters. 
CONCLUSIONS 
The quantitative tracing of the original drug in body fluids is important 
to evaluate reasonable dosage schedules of drugs. 
Pharmacokinetic factors like biological half-life time of elimination and 
distribution volume are necessary to bring more objective criteria into 
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pharmacotherapy, especially when subjective criteria are difficult to 
establish. 
The biological half-life time is controlled by the magnitude of the 
distribution volume and the clearance constant k. This parameter can be 
calculated from plasma concentration curves. The clearance constant can 
be composed of several constants such as metabolic, renal, alveolar and 
distribution clearance constants. Depending on the nature of the com-
pounds one of these constants will dominate in general. 
The fictive distribution volume of a drug at the equilibrium situation is 
considered to be constant for a special drug in an individual. 
To obtain maximum therapeutic profit and less toxic side-effects for 
chronically administered, accumulating drugs it is advisable to follow 
plasma concentrations at regular time intervals. 
Analytical problems have frequently prevented the accurate deter-
mination of drugs in the presence of biogenous compounds or structurally 
related metabolites. The introduction of radioisotope techniques in 
conjunction with chromatographical and electrophoretical separation 
techniques enabled the qualitative and quantitative tracing of drugs in the 
body. In the past, pharmacokinetic data of drugs have often been pub-
lished on the basis of the analysis of drug and metabolites together. The 
consequence can be confusing when the metabolites show no or modified 
activity. The disadvantage of many bioanalytical procedures is the 
disturbance of the physiological conditions. Homogenate-extraction 
techniques may level out specific locations. 
Our investigations deal with the distribution, elimination and bio-
transformation of ataractic drugs of the diazepine- and meprobamate-
group. 
Macroautoradiography appeared to be a valuable tool in the tracing of 
drug and metabolites in analytically difficult attainable regions. The 
experiments have been carried out in mice. Frequently, data obtained 
from laboratory animals are difficult to translate to man. 
Experiments in dogs have been carried out to get information about 
the concentration-time course with the accurate radioisotope-dilution 
analysis. They are intended as an introduction to the tracing of the drugs 
in man. 
In man, plasma is the "closest" body fluid for analysis that can reflect 
the kinetic processes in the compartment of action. Gaschromatography 
with sensitive detection enabled the quantitative estimation of the drug 
over the therapeutic concentration range. 
3° E. VAN DER KLEIJN 
LITERATURE 
A R I E N S , E. J. in : "Physico-chemical aspects of drug ac t ion" Proc 3rd. 
I n t . Pharmacol . Meet ing Sao Paulo 1966, Pergamon Press, Oxford 
1968, 7, 1. (1) 
A R I E N S , E. J. Algemene principes van de farmacologie, in : "Alge­
m e n e F a r m a c o t h e r a p y " Eds. W. L a m m e r s et al., Stafleu, Leiden 
1968. (2) 
A R I E N S , E. J., S I M O N I S , A. M . and VAN ROSSUM, J. M . in : "Molecular 
Pharmacology" . Ed. E. J. Ariens, Academic Press, N e w York and 
L o n d o n , 1964,7, 119. 
B U N G E R , P., D I L L E R , W., F U H R , J. and K R U G E R - T H I F M F R , E. Ver­
gleichende U n t e r s u c h u n g e n an neueren Sulfanilamiden. Arznetm. 
Forsch., 1961, и , 247. 
B L T L F R , T . C. T h e rate of penetrat ion of barbituric acid derivatives 
into t h e bram. J. Pharmacol. Exp. Therap., 1950, 100, 219 
DoLUisio, J. T . and SWINTOSKY, J. V. Biopharmaceutics. Amer. J. 
Pharm , 1965, 144. 
D O S T , F . H in : " G r u n d l a g e n der Pharmakokinet ik" . G. T h i e m e 
Verlag, Stuttgart , 1968. 
D O U G L A S , J. F., BRADSHAW, W. H., L U D W I G , В. J. and P O W F R S , D . 
Interact ion of plasma protein with related 1,3-propanediol dicar-
bamates. Biochem. Pharmacol., 1964,13, 537. 
G O L D B A U M , L . R. and S M I T H , P. K. T h e interaction of barbiturates with 
serum a lbumin and its possible relation to their disposition and 
pharmacological actions. J. Pharmacol. Exp. Therap., 1954, i n , 
197. 
K L F Y N , E. VAN DER. Macroautoradiography of ataractics of the mepro-
bamate-group in mice. Acta Physiol. Pharmacol. Neerl. 1969 (in 
press) 
K R U G E R - T I I I E M E R , E. Pharmacokinetics and dose-concentration rela­
tionship, in : "Physico-chemical aspects of drug ac t ion" Ed. 
Ariens, E. J., Proc. 3rd Int . Pharmacol . Meet ing Sao Paulo 1966, 
Pergamon Press, Oxford 1968, 7, 63. 
K R U G E R - T H I E M F R , E., D I L L P R , W., D E T T L I , L., B L N G E R , P. and SEYDEL, 
J. Demonstra t ion des Einflusses der Eiweiss b i n d u n g und der 
Ionisation auf die Pharmakokinetik am gaskinetischen Modell nach 
Van 't Hoff and Langmuir . Antibiotica et Chemotherapia 1964. 
12, 171. 
K R U G E R - T H I E M L R , E. and E R I K S E N , S. P. Mathematical model of 
PHARMACOKINETICS 
З
1 
sustained-release preparations and its analysis. J. Pharm. Sci., 
1966,55, 1249. 
LASTER, L. and INGELFINGER, F. J. Intestinal absorption-aspects of 
structure, function and disease of the small-intestine mucosa. 
New Engl. J. Med., 1961, 264, 1138. 
LEVY, G. Relationship between elimination rate of drugs and rate of 
decline of their pharmacologic effects. J. Pharm. Sci., 1964, 55, 
З42· 
LEVY, G. Kinetics of pharmacologic effects. Clin. Pharmacol. Ther., 
1966, 7, 362. 
LEVY, G. Effects of bed rest on distribution and elimination of drugs. 
J. Pharm. Sci., 1967, 56, 928. (ι) 
LEVY, G. Kinetics of pharmacologic activity of succinylcholine in man. 
J. Pharm. Sci., 1967, 56, 1687. (2) 
LEVY, G. and HOLLISTER, L. E. Inter- and Intrasubject variations in 
drug absorption kinetics. J. Pharm. Sci., 1964, 53, 1446. 
MAICKEL, R. P., COX, R. H. JR., MILLER, F. P., SEGAL, D. S. and RUSSELL, 
R. W. Correlation of brain levels of drugs with behavioral effects. 
J. Pharmacol, exp. Therap., 1969, 765, 216. 
NELSON, E. Solution rate of theophylline salts and effects from oral 
administration. J. Amer. Pharm. Assoc, 1957, 46, 607. 
NELSON, E. Kinetics of drug absorption, distribution, metabolism, and 
excretion. J. Pharm. Sci., 1961, 50, 181. 
RIEGELMAN, S., LOO, J. С. К. and ROWLAND, M. Shortcomings in 
pharmacokinetic analysis by conceiving the body to exhibit 
properties of a single compartment. J. Pharm. Sci., 1968, 57, 
117.(1) 
RIEGELMAN, S., Loo, J. С. К. and ROWLAND, M. Concept of a volume 
of distribution and possible errors in evaluation of this parameters. 
J. Pharm. Sci., 1968, 57, 128. (2) 
RossuM, J. M. VAN (personal communication, 19681). 
ROSSUM, J. M. VAN Pharmacokinetics of accumulation. J. Pharm. Sci., 
19682, 57, 2162. 
ROSSUM, J. M. VAN, and TOMEY, A. H. M. Rate of accumulation and 
plateau plasma concentration of drugs after chronic medication. 
J. Pharm. Pharmac, 1968, 20, 390. 
ROSSUM, J. M. VAN, and VAN KOPPEN, A. T. J. Kinetics of psychomotor 
stimulant drug action. Eur. J . Pharmacol., 1968, 2, 405. 
ROWLAND, M. and RIEGELMAN, S. Pharmacokinetics of acetylsalicylic 
acid after intravenous administration in man. y. Pharm. Sci., 1968, 
57. і З ^ · 
32 E. VAN DER KLEIJN 
R O W L A N D , M., R I E G E L M A N , S. and E P S T E I N , W . L. Absorption kinetics 
of griseofulvin in man. J. Pharm. Sci., 1968, 57, 
ScHELiNE, R. R. D r u g metabolism by intestinal microorganisms. 
J. Pharm. Sci., 1968, 57, 2021. 
SEGRE, G . Models for kinetics in pharmacology. I n t . Conf. Use Radio­
active Isotopes Pharmacol . Geneva, 1967. 
D E SILVA, J. A. F . , K O E C H L I N , B. A. and BADER, G. Blood level dis­
t r ibution pat terns of diazepam and its major metabolite in man. 
J. Pharm. Sci., 1966, 55, 692. 
U L L B E R G , S. Autoradiographic studies on the distr ibution of labelled 
drugs in the body. Proc. Second. U. N . Intern . Conf. on peaceful use 
of Atomic Energy, 1958, 24, 248. 
W A G N E R , J. G. Biopharmaceutics : Absorption Aspects. J. Pharm. 
Sci., 1961, 50, 359. 
W A G N E R , J. G., N O R T H A M , J. I., ALWAY, C. D. and CARPENTER, O. S. 
Blood levels of drug at the equi l ibr ium state after mult iple dosing. 
Nature, 1965, 207, 1301. 
W A G N E R , J. G. and M E T Z L E R , С. M . Predict ion of blood levels after 
mult iple doses from single-dose blood level data : data generated 
with two-compartment open model analyzed according to the one-
c o m p a r t m e n t open model. J. Pharm. Sci., 1969, 58, 87. 
W I E G A N D , R. G. and T A Y L O R , J. D. Kinetics of plasma drug levels after 
sustained release dosage. Biochem. Pharmacol., i960, 3, 256. 
CHAPTER II 
PROTEIN BINDING AND LIPOPHILIC NATURE OF 
ATARACTICS OF THE MEPROBAMATE- AND 
DIAZEPINE-GROUP 
INTRODUCTION 
Physicochemical properties of drugs, such as lipophilic nature, pK-
values and protein binding are impoitant factors involved in the kinetics 
of absorption, distribution, and elimination, and therefore in drug action. 
Many investigations have been published on the correlations between 
lipophilic properties of a drug, expressed as partition coefficient between 
two immiscible liquid phases, and its pharmacological activity (BUECHI 
and PERLIA, i960; BRODIE, 1964; FELTKAMP, 1965; HANKE and KLINGER, 
1957; HESS et al., 1968). 
In the field of barbituric acid derivatives onset and time course of 
action were successfully correlated with physicochemical properties of 
the compounds (BUTLER, 1950). As a general rule, "short-acting" bar-
biturates have a high partition coefficient while the "long-acting" deriva-
tives show a lower partition coefficient. Other factors as acid-base 
equilibrium in the body (/>KU), dose, route of administration and rate of 
biotransformation are important. 
Many drugs, organic as well as inorganic, are bound to some extent to 
proteins (GOLDSTEIN, 1949; MEYER and GUTTMAN, 1968). In general, 
drug-protein interaction is treated as a dynamic equilibrium between 
the drug molecules which occupy the binding sites and the drug mole-
cules which are free in solution. 
Protein binding is generally considered as an important factor in the 
distribution and elimination of drugs. The free, unbound, drug molecules 
are presumed to be available for transport to the tissues and hence 
protein binding controls the diffusion rate and the apparent distribution 
volume (KRÜGER-THIEMER et al., 1964). Mainly acidic drugs have been 
considered in these studies (MEYER and GUTTMANN, 1968). 
The purpose of this investigation was to study protein binding of 
3 
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ataractics as a factor in drug distribution, and the character of the binding 
in relation to the lipophilic nature of these compounds. 
MATERIALS AND METHODS 
The following drugs, either cold or "C-labeled compounds, were investigated with 
respect to binding to proteins and surfactants, and to partition between organic solvents 
and water meprobamate, cariboprodol (N-iso-propyl meprobamate, Apesan"), tybamate 
(N-H-hutyl meprobamate, Solacen1*), chlordia/epoxide (Librium 1 1) and diazepam (Va­
lium l , ) In drugs of the meprobamate-group the label was situated in the (unsubstituted) 
carbamate-group, in the dia/epine-group the Ca-position was labeled 
Binding was studied to dog plasma (hepanmzed, 5000 IU 1 "m bttro" and "in vivo"), 
to bovine serum albumin (cnstallyzed В S A Povite, Amsterdam), to polvsorbate 80 
(Twccn1 1 80) and to polvsorbate 20 (Tween1 1 20, Atlas Chemical Industries) 
Analytical procedures. 
1 Assay of liC -radioactibity 
1 1 Liquid scintillation counting (LSC) 
Radioactivity of protein-containing liquids was counted after mixing with 1 0 ml of 
the hydroxide of Hvamine 10 \ (Packard) or 1 о ml of о 50 M Soluene (Packard) 
Digestion with Soluene was done bv warming for 45 mm at 50CC After mixing with 
15 о ml of scintillation cocktail of Bray (1960), counting was performed with a Nuclear 
Chicago, Mark I, liquid scintillation counter Corrections were made by the external 
standard method Protein-free and surfactant-containing solutions were directly mixed 
with scintillation cocktail 
1 2 TLC-scanning 
Radioactive spots on TLC-plates were detected with a Desaga scanner (Type 12-2) 
equiped with a Berthold Zahlratenmesser LB 2031 and synchronously recorded 
2 Spectrophotometry 
2 1 Assay of diazepam and chlordiazepoxide for partition-coefficient determinations 
Concentrations of diazepam and chlordia/epoxide in samples of each of the two solvents 
were measured after acidihcation of the aqueous sample or after extraction of the organic 
sample with ο ι \ HCl, on a Beekman DB-G grating spectrophotometer (diazepam 
i^na\ 240 n m , chlordiazepoxide Amax — 245 nm) 
2 2 Assay of surfactant 
Concentrations of polysorbate 80 and polysorbate 20 were measured on a Beekman 
DH-G grating spectrophotometer (Amo\ — 232 nm) 
Supernatant solutions appeared to contain less than o os % surfactant 
3 Gas-liquid chromatography (GLC) 
3 1 Assav of meprobamate, cansoprodol and tvbamate 
Concentrations of meprobamate and its homologues were determined according to 
the gaschromatographic method of DOUGLAS et al (1967) 
Peak area were calculated as the product of height and width at half height 
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3.2. Assay of chlordiazepoxide, diazepam, oxydiazepam, dcsmethyldiazepam and 
oxazepam. 
The diazepines were determined according to the gaschromatographic method indicated 
by DE SUVA et al. (1964) and described by MARCUCCI et al. (1968) and VAN OER KLEIJN 
(1969). Since chlordiazepoxide and oxydiazepam gave poor results when directly analyzed 
with gas-liquid chromatography, these compounds were hydrolyzed with 4 N HCl 
during 1 hr in a boiling-watcr-bath. After neutralizing the liquid with Nal lCO,, methyl-
amino-5-chlor-benzophenone (MACB) and amino-chlor-benzophenone (ACB) were twice 
extracted with ether. The dried ether residues were taken up in 100 μ\ n-hexane and 
5 μ\ were injected into the GLC. 
4. Thin-layer chromatography. 
Thin-layer chromatography (TLC) on precoated silicagel glassplates F 257 (Merck 
A.G., Darmstadt, Germany) was applied. 
The following solvent systems were used : 
1. Chloroform-acetone (9 : 1). 
2. Chloroform-acetone-pyridine (75 : 25 : 5.6). 
3. Ethylacetate-n-hexane-ammonia (12 %) (60: 27 : 25). 
Solvent 3 was used for checking radiopurity of the compounds. Solvents 1 and 2 
were used to determine the migration-rate. Amounts of 5—10 ¿¿g were spotted on the plate 
and series of spots were simultaneously chromatographed at room-temperature over 
10 cm. R/ values were measured in the usual way. 
Biochemical procedures. 
1. Preparative ultracentrifugation. 
The experiments for the determination of binding to proteins and surfactants with 
ataractic drugs of the meprobamate and diazepine group were carried out in a Christ, 
Omega II 70 ultracentrifuge equiped with an auxiliary thermostatic set which allowed 
runs at o=-40 C. At 37° С temperature equilibration was performed within _!_ 0.3 3 C. 
As a rule the rotor was started at about 43 -45 ' С and a stable temperature level was 
reached after about 20 mm. Sedimentation was performed in a Ti-rotor 70 No 9798 
carrying eight polycarbonate tubes ("Oak-Ridge" Type No 2854, contents ± 11 ml) 
closed with anticorrodal screw-caps of special design to withstand 420.000 g. Runs 
were made at 70,000 rpm, 37 J_ 0.3" С for 3 hrs. 
ι.о ml of supernatant fluid was taken off and analyzed for radioactivity or protein 
concentration. 
The fraction of drug bound to protein or surfactant was calculated from the concen­
tration in the supernatant and in the original solution after correction for protein volume. 
In calculating binding parameters a correction has to be made for the relatively large 
volume displaced by the large macromolecules. According to Mc LEAN and HASTING 
( I935) the apparent concentration values in protein-containing solutions were corrected 
by multiplying with a factor ιοο;Ρ„. where : 
Pu — 99.6 — (o.75 / % protein) ml/ioo ml plasma. 
Corrections for polysorbatc 80 solutions were applied as indicated by YWIADA and 
YAMAMOTO (1965) according to : 
Ρ„. — roo — (2.0 4 % polysorbatc) ml/100 ml solution. 
2. Determination of apparent molecular weight of nonpolar surfactants (micellar weight). 
The micellar weight of a nonpolar surfactant highly differs from the real molecular 
weight of the surfactant based on its chemical element composition. 
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Molecular weight of polysorbate 80 was determined according to ARCHIBALD'S method 
using D 2 0 and H 2 0 (CDELSTEIV and SCHACHMAN, 1966, G R O O T et al, 1969) 
3 Determination of protein concentration 
Total protein concentrations were determined with the biuret method 
Protein spectra were dcnsitometncally assayed after electrophoretical separation on 
cellulose-acetate using amido-black as dye. 
4 Assay of protein binding of meprobamate, cansoprodol, tybamate, diazepam and chlor-
diazepoxide "in vitro". 
4 1 D o g plasma. 
Maximally 1 0 0 ml of aqueous solutions or suspensions of various concentrations 
were added to calibrated flasks, and the volume made up to 25 о ml with outdated, 
hepanmzed dog plasma Radioactive drug corresponding to 1000-50 000 dpm/ml of 
final solution was introduced in a volume of 0 0 5 0 ml 
Concentrated solutions of drugs, slightly soluble in water, were prepared by dissolving 
1 part of drug in 1 part of ethanol (abs ) and polysorbate 80, and by diluting with water 
to the desired volume T h e final poh sorbate concentration in the stock suspension was 1 % 
T h e p H of the solution was checked on a pH-meter, Radiometer Copenhagen type 
P H M 22 r, and was adjusted to 7 38 
1 00 ml of plasma and supernatant fluid was assayed for radioactnitv and protein 
concentrations 
4 2 Bovine serum albumin (BSA) 
10 "„ solutions of B S A in о 25 M phosphate buffer and о 25 M NaCl were made in 
stock 1 0 0 ml of stock solution was added to a calibrated flask of 25 о ml 
T h e drug was added as a 10 о ml solution or a suspension as described above Various 
drug concentrations ranging from 50 ng — 200 fig ml were investigated 
Radioactive material was introduced in a volume of о 050 ml accounting for about 
1000-50 000 dpm/ml of the final solution Volumes were made up to 25 о ml with water 
Concentrations of cold drug were considered to correspond with the weighed and 
diluted sample 
4 3 Nonpolar surfactant 
2, 5 and 10 0 0 solutions of polysorbate 20 or polysorbate 80 were investigated. T h e 
drug concentrations used were similar to those of the BSA experiments Supernatant 
solutions were spectrophotometncally checked on polysorbate concentration 
1 о ml of the original solutions and the supernatants were assayed for radioactivitv 
Results were correlated with the added drug concentrations 
5 Assay of protein binding of the ataractics in dogs "in vivo" 
Dogs, previously starved for 24 hrs, were injected intravenously with about 1-2 nC/kg 
body-weight corresponding to the doses given in Table I 
T A B L E I 
Meprobamate 2 2 - 5 0 mg/kg 
Cansoprodol 25-40 mg'kg 
Tybamate 15-30 m g kg 
Diazepam о 9—2 mg kg 
Chlordiazepoxide 1-4 mg/kg 
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Hepannized blood samples of 25 ml were taken from an implanted catheter in the 
arteria femoralis, and plasma and supernatant fluids were assayed for radioactivity. 
Protein binding of the drugs was calculated from plasma and supernatant concen­
trations within 5 mm after administration Biotransformation made accurate calculations 
impossible after 5 mm (ν·\Ν DER Κ Ι FIJN, іубд1). 
6. Determination of partition coefficients. 
Determinations of partition coefficients were carried out by shaking equal volumes 
of a water phase, buffered to pH — 7.4 with о 2 M phosphate buffer, and a with water 
immiscible organic phase. Chloroform, carbon tetrachloride, η-octanol, n-decanol and 
η-heptane were used as organic phases. 
T h e compounds were solved in cither the organic or the aqueous phase depending 
on their nature. Concentrations were determined either spectrophotometrically or gas-
chromatographically When necessary aqueous phases were titrated with ο. 1 N HCl. 
to the pH desired. The two phases were shaken for at least 24 hrs at room-temperature 
before anal) sis. 
The partition coefficients in the n-heptane-water system correspond with the ratio's 
of the concentrations of the saturated solutions of the drug 
RESULTS 
Testing of the method. 
The ultracentrifuge method was tested in order to determine the 
influence of sedimentation and temperature on protein binding. 
The shortest possible sedimentation period was found to be 2 hrs. 
Fig. 1 and 2 show that a 2 | hrs run for dog plasma is sufficient to reach 
a protein-free supernatant of 2 ml. 3 hrs of centrifugation increased the 
security and was used throughout this study. The 5 hrs period resulted in 
the pattern as reported by SCIIOLTAN (1965). 
After the 21 hrs period a plateau level at which drug and protein are in 
equilibrium could be distinguished in the centrifuge tube. At longer 
sedimentation periods the plateau level faded out ( F I G . I ) . In the BSA-
experiments the lower protein concentration (4 %) resulted in a higher 
sedimentation rate and hence in a greater protein-free supernatant 
volume ( F I G . 3). 
The duration of the sedimentation period had no influence on the 
concentration of the drug in the protein-free supernatant solution 
( F I G . I ) . 
The influence of the temperature was studied by centrifugation at 
37o, 20o and i5 c C respectively. At lower temperatures higher protein-
binding capacity was observed ( F I G . 4). According to SCHOLTAN (1964) 
this phenomenon is more pronounced for substances with a low protein-
binding capacity. 
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DISTRIBUTION OF DIAZEPAM IN A CENTRIFUGE TUBE 
d i a z e p a m (¿ jg /ml) 
10 ( m l ) 
FIG. ι 
Influence of sedimentation period on the volume of supernatant. 2 J hr of centrifugation 
of plasma might be sufficient to obtain a 2 ml protein-free supernatant. 
Binding parameters. 
For the estimation of the binding parameters the reciprocal plotting 
method of KLOTZ (1946) was used {r is the fraction of macromolecules 
occupied by drug molecules). 
Binding of ataractic drugs to plasma proteins and nonpolar surfactants 
is summarized in Table II. 
Fig. 5 and 6 indicate that the binding capacity shows little or no depen­
dence on the total drug concentration in solution. 
Figures 7 and 9 show the relation between i/r and i/fA^. The 
reciprocal slopes are summarized in Table III. The ordinate intercept is 
difficult to determine. It appeared that this intercept which yields the 
\'alue i/n is considerably lower than 1. 
TADLE II 
Binding capacities of the ataractic drugs studied. The concentrations f or which the values hold are given in figures 5 and 6 
% Binding 
Dog plasma 
ultraccntnf. 
"in vitro" 
37" С 
Human plasma 
dialysis 20° С 
DOUGLAS e.a. 
(1964) 
Polysorbate 
80 
ultracentrif. 
5 % , 37'- С 
Polysorbate 
20 
ultracentrif. 
5 % , 37° С 
BSA 
ultracentrif. 
4 % , 37° С 
Dog plasma 
ultracentrif. 
"in vivo" 
37° С 
Mcprobamate 
Carisoprodol 
Tybamate 
45-47 
63-71 
55 
77-81 
5 0 
73 
42 
66 
78 
38 
46 
59-65 
8-13 
41-44 
54-70 
Chlordiazepoxide 86-87 93 93 87 89.1-92.5 
Diazepam 93-94 95 92 84-87 89-3-940 
1 
I 
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D I S T R I B U T I O N OF T Y B A M A T E IN A C E N T R I F U G E T U B E 
tybamate (μς/ml) — —^  protein (°/o) 
1.5 
1.0 V 
0.5 
10 (ml) 
F I G . 2 
ж irj, л 
Example of the distribution pattern of tybamate in a centrifuge tube after 21 hr of 
ccntrifugation of dog plasma. The existence of a plateau level can vaguely be distin­
guished. 
TABLE III 
Binding parameters of ataractic drugs with BS A and nonpolar surfactants 
Binding of ataractic drugs to BSA and nonpolar surfactants 37o С 
Drug 
Meprobamate 
Carisoprodol 
Tybamate 
Chlordiazepoxide 
Diazepam 
KA · η [io3] 
BSA 
L I S 
ι.41 
2.82 
10.5 
10.4 
Polysorbate 
80 
1.56 
1.56 
2.67 
22 
25 
Polvsorbate 
20 
1.04 
2.48 
4-32 
22.6 
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D I S T R I B U T I O N OF D I A Z E P A M I N A C E N T R I F U G E T U B E 
χ 10^ d . p . m . 
10 
10(ml) 
F I G . 3 
Distribution of diazepam in a centrifuge tube after 3 hr centrifugation of BSA solution 
(4 % ) . Here a greater protein-free supernatant volume is achieved in the same period 
as in Figure 1. 
TADI-E IV 
cone. 
% w/v Soo value 
M.W. 
micelle 
M.W. (') 
substance ¿25 (') 
polysorbate 20 | 
polysorbate 80 I 
0.8 
0.8 
232 nm 
232 nm 
1-3 
1.6 
60,000 (2) 
74,400 
1200 
1470 
1.013 
1-075 
C1) Data of BECHER (1968). 
(2) The micellar weight of polysorbate 20 has not yet been determined exactly; in 
calculations the value given was used. 
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This implies that more than ι drug molecule binds to ι protein 
molecule or micelle. 
For the calculation of i/r the molecular weight of the macromoleculcs 
has to be known. For BSA the generally accepted molecular weight of 
69.000 was used. 
Results of the estimations on the polysorbates are given in Table IV. 
D I S T R I B U T I O N O F D I A Z E P A M I N A C E N T R I F U G E T U B E 
d i a z e p a m ^ g / m l ) p r o t e i n (%) 
Distribution patterns of diazepam in dog plasma. 
Influence of temperature on sedimentation time. At lower temperature higher viscosity 
influences the sedimentation rate and subsequently the volume of the protein-free super­
natant. Protein concentrations are given from the 37° С experiment. 
Partition coefficients. 
Determination of partition coefficients of the ataractic drugs was 
complicated by the extremely low solubility of the compounds in water 
and the high solubility in most organic solvents. Therefore differences in 
lipophilic character between diazepam, chlordiazepoxidc and tybamate 
could only be established in the heptane-water-system (TABLE V). 
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True partition coefficient (TPC) values with other organic solvents are 
also given in Table V. TPC-values of diazepam and chlordiazepoxide 
were calculated from the apparent partition coefficient (APC) values 
( F I G . 10). 
PROTEIN-BINDING IN DOGPLASMA 
0/o b o u n d 
ЮО-
и-и—ш-
60 
60 
• · 
Охэ—о-
40 
20 
3 7 0 C 
70 000 r .p .m 
3 h 
% free 
г 0 
d i a z e p a m 
chlordiazepoxide 
t y b a m a t e 
cccrisoprodol 
20 
- 4 0 
m e p r o b a m a t e 
ρ 
60 
-Θ0 
•100 
10 
F I G . S 
12 14 16 (^g/ml) 
Diagram demonstrating the protein-binding capacities of dog plasma for ataractics 
"in vttro" in the therapeutically achievable plasma concentration range The protein 
binding is not or only slightly dependent on the concentration 
Revalues. 
Besides by partition coefficients and protein binding, lipophilic nature 
might be characterized by migration rates in chromatography represented 
by R/'Values. Table VI provides information about the relative lipophilic 
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character of the compounds. Thin-layer chromatography on silicagel 
plates in the given solvents appeared to give suitable data. Chlordiazepox-
idc is less lipophilic than diazepam, which correlates well with the rate of 
TABLE V 
Partition coefficients characterizing the lipophilic nature of drugs 
Drug 
Diazepam 
Oxy diazepam 
Desmethyldiazepam 
Tybamate 
Chlordiazepoxide 
Carisoprodol 
Meprobamatc 
Oxazepam 
True partition coefficient 
Orcanic solvent 
Water 
я-Heptane 
1 5 0 
1,4 
0 , 6 
0.49 
o.a 
0.04 
0.003 
< 0.01 
n-Octanol 
1 8 0 
4 0 0 
1 3 0 
8 0 
1 8 
pH - 7.4 
n-Decanol 
2 8 0 
4 0 0 
1 7 0 
4 0 0 
8 0 
23° С 
Chloroform 
1000 
4 0 0 
55° 
4 0 0 
3-5 
TABLE VI 
Rf — values characterizing the lipophilic nature of drugs 
R/ — value χ 100 
Drug Solvent 
Thiopentone 
Hexobarbitone 
Diazepam 
Oxydiazepam 
Tybamate 
Carisoprodol 
Phenobarbitone 
Barbitone 
Desmethyldiazepam 
Phenazon 
Oxazepam 
Meprobamate 
Chlordiazepoxide 
Urea 
91 
82 
76 
67 
56 
55 
52 
51 
44 
32 
24 
19 
19 
2 
72 
67 
64 
58 
59 
58 
57 
56 
55 
46 
39 
38 
35 
3 
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penetration of the drugs into the brain (VAN DER KLEIJN, 1969). The 
same phenomenon was demonstrated for drugs of the barbiturate-series 
(CASSANO et al., 1967). 
BINDING TO 4 % BOVINE SERUM ALBUMIN 
% b o u n d 
100 
80 
60 
40 
20 
Î - S · 
0 η о 
D π 
u 
D 
3 7 0 C 
70 000 r.p.m. 
3 h 
1
 1 τ — • τ • 
·-
— t 
- ъ — 
chlordiazep oxide 
diazepam 
tybamate 
• - Δ . 
carisoprodol 
0 
π „ 
meprobamate 
τ 1 1 1 l 
% free 
г 0 
20 
40 
60 
- Θ0 
100 
6 8 10 12 14 16 (яд/ml) 
FIG. 6 
Diagram demonstrating the binding capacities "in vitro" of BSA in the therapeutically 
achievable plasma concentration range of drugs and protein. 
DISCUSSION 
The main requirement of the methods for determination of protein 
binding is the imitation of the free, unbound, drug concentration in 
equilibrium with the drug-protein complex in physiological circum-
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stances, since the free concentration is supposed to be responsible for 
diffusion to the biophase and hence for the pharmacological activity. 
The classical and still most frequently applied method for the estima­
tion of protein binding is the equilibrium dialysis technique (KLOTZ, 
BINDING TO BOVINE-SERUM-ALBUMIN 
, 4 % 37 0 C 
100 
:o 20 30 40 ямоУтоі 
F I G . 7 
Protein binding to BSA plotted according to KLOTZ (1946). Parameters are given in 
Table III . 
1947; SPRING, 1966, and others). Although this method has been proved 
to give reliable results for other drugs, difficulties arose inherent to the 
materials and the equilibration time. 
Other methods like ultrafiltration, electrophoresis (SCHOLTAN, 1962), 
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gel-filtration (KRIEGLSTEIN and KUSCHINSKY, 1968, 1969), analytical 
centrifugation (STEINBERG and SCHACHMAN, 1966), conductivity measure-
ments and preparative ultracentrifugation (BÜTTNER and PORTWICH, 
1961 ; SCHOLTAN, 1965) are used. 
The preparative ultracentrifuge technique has been improved and 
appears to have certain advantages over other methods because of its 
fast and reproducible results, while absorption phenomena are lacking. 
BINDING TO POLYSORBATES 
% f r e e 
100 
80 
60 
40 
20 
37° С 
60 000 r .p.m. 
15 h 
8 0 
|- — % bound 
Г
 0 
20 - 20 
meprobamate 
chlordiazepoxidc 
diazepam 
2 0 50 100 
4 0 
- 60 
80 
50 
polysorbate (g/l) 
F I G . 8 
Binding capacities of the polysorbates 80 and 20 for ataractic drugs. 
SCHOLTAN (1965) found that the equilibrium situation during cen­
trifugation is in accordance with the theory of GILBERT and JENKINS 
(1959). The synchronous sedimentation of drug-protein complex and 
protein as well as the existence of a level where all components are in 
equilibrium was confirmed. The latter phenomenon could only be 
achieved in a swinging-bucket rotor. 
The sedimentation rate is a function of e.g. rotation rate and hence of 
the number of revolutions per minute to the second power, of tem­
perature and concentration of solutes and hence of the viscosity (SVED-
BERG, 1959)· Thus the sedimentation time is inversely proportional to the 
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number of rpm to the second power. Increase in temperature and decre-
ase in protein concentration result in a decrease in viscosity. The in-
fluence of the viscosity was not closely investigated. On the basis of the 
data of BÜTTNER and PORTWICH (1961) a run period of 5 hrs was cal-
culated at 70 000 rpm. 
BINDING TO POLYSORBATES 
37 °C 
chlordiazepoxide 
' "^ ΐΐ 
diazepam L j^J 
40 50 103/mol 
F I G . 9 
Binding of ataractic drugs to polysorbate 80 and polysorbate 20. 5 % 
polysorbate 80 solutions, • • and · · S % polysorbate 20 solution 
— · — · — • — 2 % and 10 % polysorbate 80 solutions. T h e slopes are given in Table IV. 
Meprobamate U and •, carisoprodol О and · , tybamate Δ. 
Electrostatic equilibrium. 
For solutions in which a mechanical separation takes place between 
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Λ PC 
TPC=2APC ( p H
=
p k
a
) 
1 2 3 4 Ь p.-, 
KlG. IO 
Plot of APC against pH for calculation of the partition coefficients of the neutral form. 
О О chloroform-water system. 
Δ Δ n-decanol -water system. 
D Π η-octanol -water system. 
charged particles of different molecular shape, corrections have to be 
considered. 
In the ultracentrifuge technique the phenomena involved in this 
equilibrium can be distinguished as a primary and secondary salt effect 
(PEDERSEN, 1958). 
The primary salt effect gives rise to reduced sedimentation of the 
charged macromolecule, because of a concentration gradient that is set up 
when the opposite charged particles have different sedimentation con­
stants. As a result there will be an acceleration of the slow sedimenting 
4 
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ions and a retardation on the colloidal ion since the condition of electrical 
neutral i ty m u s t be fulfilled. Addition of neutral salts to the solution 
diminishes the potential gradient in a similar way as in the case of diffu­
sion or of Donnan-equi l ibr ium. 
T h e secondary salt effect will occur even in more concentrated solu­
tions when opposite charged ions set u p an electrical gradient dur ing 
centrifugation of unequally dense ions, e.g. CsCl. T h e s e effects have been 
neglected in our experiments . 
Adsorption and polymerisation. 
I n equi l ibr ium dialyse technique adsorption to the m e m b r a n e has to be 
expected ( R O D R I G U E S DE M I R A N D A , 1967). Adsorption of radioactive 
material and polymerisation of t h e d r u g molecules leading to the forma­
tion of drug micelles might take place (JAENICKE, 1966). 
I n protein-free solutions no sedimentation u n d e r the same experimen­
tal circumstances could be established. 
N o adsorption on polycarbonate centrifuge tubes could be measured. 
pH. 
T h e influence of the p H on binding can be important u n d e r ex­
perimental conditions ( G O L D B A U M and S M I T H , 1954). 
M e p r o b a m a t e homologues are neutral c o m p o u n d s ; diazepam and 
chlordiazepoxide are very weak bases (/>Κ„ : 3.3 and 4.8 resp.), and are 
therefore practically neutral at the blood pli. In physiological c ircum­
stances, plasma pli variations are small and subsequent influence on 
protein binding is negligible. 
Storage. 
Bacterial contamination of the sample may change the b inding capacity 
( S C H O L T A N , 1962). Several ways of preservation are investigated by 
K U R Z and T R U N K (1968). Storage at 3-4 0 C for a period of 12 m o n t h s had 
no influence on the binding capacity of plasma. Other methods, especially 
freeze-drying, were proved to be less favourable. 
Treatment of the data. 
Presentation of the percentages of drug b o u n d and free drug is of little 
importance unless the concentration range is mentioned ( G O L D S T E I N , 
1949)· 
Drug-macromolecule interaction can be described as a reversible 
bimolecular reaction characterized by an association or a dissociation 
constant according to the mass-action law. 
PROTEIN BINDING AND LIPOPHILIA OF ATARACTICS 51 
T h e fraction of total protein to which drug molecules are b o u n d may 
be represented by the following equation ( K L O T Z , 1946) : 
m
_ ηΚ
Α
[Α
ν
]
 o r
 ^ » [¿ r ] 
Th i s equation can be rearranged to 
I = b 1 x 
nKA [ Л Р ] 
\PA] 
r = = fraction of macromoleculcs occupied by drug molecules 
[' ti 
η = number ot independent binding places, demonstrating the same affinity, 
while no mutual interaction takes place. 
KA = association constant 
[Af] unbound-drug concentration 
[PA] = bound-drug concentration 
[Pf] = total protein concentration 
W h e n i/r is plotted against i/[Ap], и can be found as the reciprocal 
value of the ordinate intercept and К д can be calculated from the slope 
( і / и К д ) ( F I G . 7 and 9). 
T o include more classes of binding places, saturation of t h e first class 
must theoretically be fulfilled. In our experiments the solubility of the 
c o m p o u n d s was extremely low, which made experiments possible only in 
dilute solutions. 
T h e b inding of ataractic drugs to plasma proteins of dogs "in vivo" and 
"in vitro" and to BSA and surfactants "in vitro" appeared to show little 
dependence on the concentration over a wide range. 
Similar findings have been reported for other drugs, for instance, 
heart glycosides by SCHOLTAN (1966) and K U S C H I N S K Y (1969), chlor-
promazine and promazine by K R I E G L S T E I N and KUSCHINSKY (1968, 
1969), and medazepam by RIEDER et al. (1969). 
For all c o m p o u n d s used in this study, by reciprocal plotting according 
to K L O T Z a straight line was found ( F I G . 7 and 9). N o exact values for 
the a m o u n t of b inding places (n) could be established since it was ex­
perimental ly impossible to reach high enough drug concentrations, 
equimolar to protein or surfactant, because of the low water solubility of 
the c o m p o u n d s and because і/я was found to be m u c h lower than 1. 
r 
Plott ing - - - versus r according to SCATCHARD (1949) gave no better 
[A] 
information about и. 
Similar experiments were carried out with nonpolar surfactants. 
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Nonpolar surfactants were chosen in order to exclude the contributions 
of possible electrostatic phenomena between the basic diazepins and the 
anionic sites at the protein molecule. Polysorbates have the advantages 
over plasmaproteins of greater stability and constant quality. 
T h e close resemblance of the binding might suggest similar phenome-
na of solubilization by micelles that might also take place in blood. Both 
in protein and micelle binding, predominant ly VAN DER WAALS forces 
must be considered (SCHOLTAN, 1964). 
T h e binding by micelles may also be characterized as a partit ion 
between the water and the micellar phase, and subsequent ly micellar 
parti t ion coefficients can be calculated (YAMADA and YAMAMOTO, 1965). 
When a compound, solved in liquid, is brought in contact with another 
immiscible phase a constant concentration ratio will arise. T h i s constant 
holds for the ideal case that the liquid phases are completely immiscible, 
that the solute cannot associate or dissociate in either of the two phases, 
and that the concentrations of the solutes are relatively low (REESE et al., 
1964). 
T h e partit ion coefficient is in general an apparent parti t ion coefficient 
(APC) which is defined as : 
APC --- CV'C, 
Cj and Cg represent the concentrations of the solute in the organic (1) 
and in the aqueous (2) phase. T o yield the t rue partit ion coefficient 
(TPC) , being the quotient of the concentrations of the neutral form in 
both liquid phases (REESE et al. 1964), the APC has to be corrected. 
For a base the well-known HENDERSON-HASSELIÎALCH equation can be 
read as : 
TPC APC{\ + ΙΟ"1'"-'1") 
T h e choice of the system to determine partit ion coefficients is of 
importance since it is often very difficult to collect drugs of highly 
different physicochemical properties into one system. Mineral oils 
( D O U G L A S et al., 1964), chloroform, heptane ( B R O D I E , 1964), и-octanol 
( H A N S C H et al., 1967), oleyl alcohol ( B U E C H I and PERLIA, i960) and 
systems of controlled polarity ( F E L T K A M P , 1965, and others) are used 
against water or buffer solutions. 
Reversed thin-layer partit ion chromatography according to BUECHI and 
FRESEN (1966) appeared not to be useful for the highly lipophilic com­
pounds . 
Some of the c o m p o u n d s studied showed an extremely high lipid 
solubility which m a d e direct measurements of T P C ' s inaccurate. APC's 
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of diazepam and of chlordiazepoxidc were determined at different />H-
values and TPC's were calculated from the APC's constructed at the 
pH equal to the pK
a
 ( F I G . IO). 
A close parallel between lipophilic nature and protein binding capacity 
was earlier reported by DOUGLAS et al. (1964) for the meprobamate-
group and could be deduced from the data given by GOLDBAUM (1954) 
and FELTKAMP (1965) for barbiturates. 
In the groups of ataractics used in this study lipophilic nature ex­
pressed as partition coefficients or Revalues cannot similarly be com­
pared to the binding parameters. Chordiazepoxide, which shows a higher 
protein-binding capacity, shows a lower partition coefficient and Revalue 
than tybamate. 
Diffusion coefficients measured through artificial membranes and 
permeability coefficients measured in artificial monolayers of membrane 
lipids can also be used to simulate the behaviour of drugs in biological 
systems (DoLUisio and SWINTOSKY, 1964; KHALIL and MARTIN, 1967; 
GARRETT and CHEMBURKAR, 1968; VAN DEENEN and DEMEL, 1965). 
DAVIS (1943) postulated that of chemotherapeutics that are partially 
bound to plasma proteins only the unbound fraction of the drug should 
participate in the chemotherapeutic action. Later this hypothesis was 
substantiated by many authors for many sulfonamides and antibiotics 
"in vivo" as well as "in vitro" (ANTON, 1961, SPRING, 1966). MARTIN 
(1965) calculated that compounds, having no tissue constituent binding, 
will only be restricted in their elimination from the blood by protein 
binding, if the association constant (Кд) is greater than io 4 . 
Influence of protein binding on the distribution and elimination 
kinetics of drugs has been reported for sulfonamides, antibiotics and 
radiopaques when excretion is predominantly controlled by renal glomer­
ular filtration (SIROTA et al., 1950; KUNIN, 1962; KRÜGER-THIEMER, 
1965, ENGELEN, 1968). However, this is not observed with the ataractics 
used in this investigation. 
Meprobamate showed the lowest penetration rate into the central ner-
vous system. However, diazepam which is highly bound to plasma pro-
teins was rapidly eliminated from the blood and rapidly taken up by the 
brain and other organs and tissues (VAN DER KLEIJN, 1969, 1, 2). 
It may be concluded that the influence of protein binding on the 
elimination of the drugs from the blood is compensated by the lipid 
solubility. 
It has been suggested that the concentration of the unbound drug in 
plasma is directly correlated with the drug concentration in other body 
compartments and that protein binding will influence the apparent 
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distribution volume. Both plasma and plasmawater can be considered as 
separate compartments closely related by the binding parameters. The 
influence of these parameters on pharmacokinetics may be intricated when 
several binding places and classes are present (KRÜGER-THIEMER, 1964). 
The concentration indépendance of the protein binding of ataractics 
enables the calculations of apparent distribution volumes on the basis of 
plasmawater concentration by multiplying the plasma-concentration 
with a simple term. 
SUMMARY 
The binding of meprobamate, carisoprodol, tybamate, chlordiaz-
epoxide and diazepam to proteins and nonpolar surfactants was studied 
with the use of the preparative ultracentrifuge technique. Binding 
appeared to be independent of the drug concentration over the thera-
peutically possible plasma concentration range. 
Protein-binding phenomena of the compounds are suggested to be 
nonspecific and comparable to those involved in solubilization by 
micelles. 
Plasma protein binding is correlated with physicochemical properties 
like partition coefficients between two immiscible phases. In addition 
the significance of protein binding on the rate of penetration of ataractic 
drugs into the central nervous system is discussed. 
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CHAPTER III 
WHOLE BODY AUTORADIOGRAPHY 
Application to water- and lipid-soluble and 
volatile compounds 
INTRODUCTION 
Since the introduction of contact autoradiography of whole animals in 
distribution studies of drugs, biogenous compounds, environmental 
pollutants, poisons etc., progressively increasing information has become 
available. 
The most frequently used method today was first published by U L L -
BERG (1954) for ^^-benzylpenicillin. Many radioactive elements have 
been tested for their utility (ULLBERG, 1961 ; FORBERG et al., 1964). The 
photographic material is generally the limiting factor in the choice of the 
radiosource. 14C-, 3 5 5 - and './/-compounds are suitable for qualitatively 
good pictures. 
The histological fixation by lyophilization enabled the permanent 
localization of drugs in organs and tissues not easily available for analysis, 
without postmortal diffusion and exchange or disturbance of the "in vivo" 
situation. This technique, however, is restricted to the application of 
non-volatile compounds. 
In the research of drugs with highly specific action and localization 
after relatively low doses, this technique has many advantages when 
combined with the classical tissue extraction-separation procedures. 
Quantitative analysis of the pictures has been difficult since densito-
metrical measurements suffer from inaccuracy. 
The frequent simultaneous appearance of radioactive metabolites 
diminishes the value of the interpretations on the parent drug in the 
autoradiograms. Radiochemical separation techniques or selective 
labeling at a position of the drug which is primarily metabolized and 
excreted increases the value. When metabolism of drugs leads to the 
formation of volatile radioactive products, simultaneous application of the 
lyophilizing and non-lyophilizing procedures increases the information. 
6ο 
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In this chapter the technique of the "whole body" autoradiography is 
described. 
lest animals 
Mice, rats, gcrbils, foetus and organs of greater animals, fishes and other animals 
can be used The dimensions of the object are limited b> the capacity of the microtome. 
Materials. 
Carboxvmethv[cellulose (medium viscosity), halothane (Fluothane1 1 ICI), solid carbon 
dioxide, isopentane (technical grade), magic transparent Scotch tape No 810 (3 M Leiden, 
Holland) 3 J inch and 1 3/4 inch for twin- and solosectioning, respectively , double-coated 
Scotch tape No 666 3/4 inch (3 M Leiden, Holland), G 5 nuclear emulsion Gclform 
(Ciba Ilford, Amsterdam, Holland), Rontgen-hlmStructunx-D? (Agfa-Gevaert, Rijswijk, 
Holland) and Mylar Polyvinylchloride foil, 3 65 μ thick (Dupont, The Hague, Holland). 
TABLE I 
Survey of the most frequently used β -radiating isotopes 
Particle Dose/kg Photographic Exposure 
Isotope energy bodv-weight emulsion time 
' Η 1 0018 Mev j 5-20 mC ] G 5 emulsion 30-150 d 
1 ' Structunx-Dy 
•"•'S 0.167 Mev 0.500-3 mC Structurix-D7 5-60 d 
Dentus Rapid 
X-ray film 
1 4 C 0 1 5 5 M e v [ 100-500 /uC " 15-80 d 
DOSAGE PROCEDURFS 
Preparation of dosage form. 
Parenteral and enteral administration Water-soluble compounds arc dissolved in 
physiological salt solution and buffered to pH 3-9 Water-insoluble compounds are dis­
solved in a suitable volatile organic solvent After addition of polysorbatc 80 the solvent 
is evaporated and physiological salt solution is added to the desired volume Solutions 
and suspensions are prepared to be administered in 5-10 ml kg 
Suppositories f or rectal administration The drug is dissolved or suspended in the suppo­
sitory base by melting or by means of a volatile solvent which is evaporated afterwards 
Treatment of the animals. 
Parenteral administration Intravenous injection is applied in the caudate vein. Intra­
muscular injection is applied in the hind leg or in the fish tail Other ways of parenteral 
administration are applied in the common way 
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Oral administration. Small laboratory animals receive the drug via an intragastric 
canule, so that solutions, suspensions or solids are administered directly into the stomach. 
Rectal and topical administration. The drug is administered in 2 g suppository base/kg 
by means of a canule (diameter inside 0.8 mm). After administration the rectum is ligated 
under local anaesthesia. Topical administration can be performed according to KOLB 
et ai. (1967). 
The animals are separately isolated in gauze cages to prevent contamination of skin 
or mouth with radioactive material. 
PROCEDURE 
At chosen survival periods after administration of the labeled com-
W 
hf to 
sg wf 
ty es In th mc Ы gb 1 u b ef e t 
nc lg с ρ cb cm 
tn, _-- ^ F - - ^ _ 
bm m 
ι 
ι 
hf to In sg 
Legend of the abbreviations. 
A adrenal gland H F hair follicle R rectum 
BF brown fat I intestine S stomach 
BL blood К kidney SC spinal cord 
BM bone marrow L liver SG salivary gland 
С cerebrum L G lachrymal gland SK skin 
CB cerebellum L N lymphe node SP spleen 
CM cervical muscle LU lung Τ testis 
D diaphragm M muscle (skeletal) T H thymus 
E epididymis MC myocardium T X trigeminal nerve 
EF epididymal fat NC nasal cavity T O tooth 
ES esophagus Ρ pituitary gland TY thyroid 
GB gall bladder PA pancreas UB urinary bladder 
W F white fat 
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EXPOSURE SANDWICH 
СП 
^ iL·' ^ . ρ 
=-—-с 
.в 
1,1
 ju; 
F I G . ζ 
Schematic representation of card-board for whole body autoradiography. 
I. Water- and lipid-soluble compounds. 
A. plank, B. card-board, C. double-coated Scotch tape, No. 666, D. Scotch tape No. 8io, 
E. object, F. Röntgen-film, G. foamed plastic or filter paper. 
II. Volatile compounds. 
A, B, C, F, foil, E, D, G, ... A. 
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pound the animals are lightly anaesthetized with halothane. Before being 
sacrificed, the animals are stretched in forceps of special design to enable 
a reproducible position. The animals are killed by immersion into isopen-
tane cooled with solid carbon dioxide to about -8ocC. This method causes 
instantaneous death without asphyxia. 
The animals are preserved on solid carbon dioxide before further 
processing. The objects are embedded in molds with a 5 %-solution of 
carboxy-methylcellulose, cooled to o c C. The mass is cooled again by 
solid carbon dioxide and stored at -is^C. 
Sagittal sections of 10-80 μ are made by a hydraulic driven Leitz 
sledge microtome, type 1300 or a Jung Ä"-microtome, No. 171, type 
Ullberg, in a freezer at -I5°C. The sections are made at several heights 
through the whole animal till all organs of interest are collected (FIG. I ) . 
The sections adhere to Scotch tape No. 810 during sectioning. The 
tapes with sections are transferred to card-boards (FIG. 2) and lyophilized 
in the freezer during 24 h. The card-boards are prepared with two 
parallel double-coated adhesive tapes (Scotch tape No. 666). Strips of 
Structurix-Dy film are pressed against the tapes and stored for exposure 
as long as necessary (355 and UC). Tapes from sections with 3H are 
adhered to glass-plates coated with G 5 emulsion. The whole procedure 
is carried out at -I50C. Films are removed at roomtemperature and 
developed according to common procedures. 
Autoradiograms arc selected and judged either directly (black area 
means presence of radioactivity) or enlarged on photographic paper 
(white area means presence of radioactivity). 
Volatile compounds. 
Compounds, volatile or liquid at roomtemperature, are handled according to the same 
procedure up to and including the slicing step. The histological sections are kept separate 
from the Röntgenfilm by Mylar foil (WIJHELS, 1969). Card-boards are handled in a dif-
ferent way. The sequence in the preparation of the card-board for volatile compounds is 
given by : A, B, C, F, foil, E, D, G, ... A. The Ivophilization step is prevented. The slices 
are immediately brought in contact with the film and stored m a freezer at —8oJ C. 
The films are exposed four times longer than necessary in the previous procedure. 
After four weeks no appreciable loss of water could be observed. 
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CHAPTER IV 
K I N E T I C S O F D I S T R I B U T I O N A N D M E T A B O L I S M O F 
A T A R A C T I C S O F T H E M E P R O B A M A T E - G R O U P IN M I C E 
INTRODUCTION 
In the t reatment of anxiety and psychic tensions, besides meprobamate , 
the N-isopropyl- and N-n-butyldcrivatives are used. Carisoprodol 
(Apcsan1 ·) and tybamate (Solacen") respectively, show a n u m b e r of 
common pharmacological properties with meprobamate . 
T h e substi tuted derivatives are more lipophilic than the parent com-
pound, as shown by partition coefficients and other physicochemical 
parameters (DOUGLAS et ai, 1964; VYN DER K I . E I J N , 1968). 
Differences in lipophilic nature have been correlated with pharma-
cokinetics of penetrat ion into the central nervous system, of elimination 
and of metabolism (BRODIE et al., i960 ; CASSANO et al., 1967; H E S S et al., 
1968; VAN DER K L E I J N , I 9 6 9 ; KuNTZMAN et al., 1967; GAUDETTE and 
BRODIE, 1959; L I E N and H A N S C H , 1968). T h e distr ibution of tritiated 
meprobamate according to the Ullberg technique has been studied by 
EWALDSSON (1963). His findings could be confirmed with 1 4 C-mepro-
bamate (VAN DER K L E I J N , 1967). 
In this investigation the distribution of meprobamate , carisoprodol and 
tybamate, following different routes of administration at several survival 
periods was studied in male and pregnant female mice. 
T h e first goal was to s tudy the comparative distribution pat tern of the 
three compounds and to interpret the patterns with those of the body 
volume indicators urea, phenazon, inulin and high molecular dextran. 
T h e second goal was to correlate the results with the aid of the physico-
chemical properties of the compounds . 
MATERIALS AND M E T H O D S 
Mcprobamatc-carbamate-^C (spec. act. : 5.5 mC/mMole) was obtained from Volk, 
Radiochemical Company, Burbank, Calif., USA. Carisoprodol-(spec. act. : 1.96 mC/ 
5 
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mMole ) and tvbamate-carbamate- 1 1C (spec. act. : 6.ζ mC/mMole) were generously 
supplied by Wallace Laboratories, Cranbury, N.Y., U S A . T h e chemical and radiochemical 
purity of the compounds was checked by thin-layer chromatography ( T L C ) and by 
subsequent scanning with a Desaga-scanner type (12-2). All compounds did contain 
less than 1 % impurities. If necessary the compounds were purified by T L C . Bands 
corresponding to the parent compounds were scraped off and were prolonged eluted 
with dried aceton p.a. 
Atitoradiography. 
Adult, male Swiss mice (average weight 20—22 g) and pregnant female mice two days 
before delivery (body-weight about 40 g) were used. T h e doses given are summarized 
in Table I : 
Т А Ш Е I 
1
 Route of administration 
D r u g
 | 
¡ Intravenous Oral Rectal 
Meprobamate 120 m g / k g 1 200 με'kg 120 m g kg 100 με; kg 120 mg/kg 100 μc/kg 
Carisoprodol 120 200 140 100 
Т у hamate 80 200 | 145 100 
For intravenous (i.v ) and oral administration the compounds were dissolved in di-
chlormethane containing polysorbate 80. T h e solvent was evaporated and the residue 
solubilized in 0.9 n
n
 NaCl-solution. T h e final polysorbate-conccntration was 2 "o. T h e 
mice received 0.01 ml/g body-weight. Injection was given in the caudate vein. Oral 
administration was performed by a cánula into the stomach. For rectal administration 
the drugs were solved either in a mixture of macrogol 1500, macrogol 4000 (1 : 2) or in 
Es tannum Β ζ g/kg was given in solid state by a cánula (internal diameter 1 mm). After 
application the rectum was hgated under local anesthesia of hdocame. 
Immediately before sacrifice, the mice were lightly anesthetized with halothane, 
stretched, and rapidly frozen by immersion in isopentane, cooled to about —70 ' С with 
solid carbon dioxide. Stretching was performed in forceps of special design to improve 
the reproducebihty of the sections of various animals. 
Autoradiographic technique according to U L L B E R C (1954, 1958) was used. T h e frozen 
animals were embedded in cooled carboxy methyl cellulose (5 "o) solution, and were 
rapidly frozen again in solid carbon dioxide. 
Sagittal sections, 30 μ thick, were made, simultaneously through two animals, in a 
refrigerated room (temperature about — 1 2 0 C) with a hydraulic driven Leitz-sledge 
microtome 1300. After adhering to Scotch T a p e (Permanent Mending Tape N o . 810, 
3 M Co., U S A ) the sections were freezedncd and pressed on to Structunx (Gevaert) 
D 7 X-ray films and exposed for 15-40 days at — 1 2 " C. 
Survival periods between 4 0 sec and 8 hours were chosen. 
Tissue analysis of carisoprodol. 
Male Swiss mice, previously fasted for 24 hours, were injected intravenously in the 
caudate vein with 50 mg (280 μ ^ , ^ carisoprodol. T h e y were killed 30 sec, 1, 3, 5, 
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io, 20, 40 and go min after administration, brains, hearts, lungs and livers were removed, 
and weighed The organs were homogeni7cd with an Lltra-Turrax T P i8'2, in 2 vol 
of saturated KCl solution containing о 1 0 0 KCN The tubes and homogcnizer were 
rinsed The decanted homogtnates and rinsing fluids of each sample were collected 
and made up to 10 о ml 
1 о ml of each homogenous fluid was transferred to a countvial and assayed for radio­
activity 
The remaining portion of the fluid v\as transferred into 40 ml tubes and extracted 
twice with 10 ml chloroform-carbontetrachlonde (1 1), followed by two more extractions 
with 10 ml eth\lacetate The organic phases were collected and evaporated 
The residue was transferred quantitatively to thin-layer chromatography plates 
(TLC-plates) and developed 
The remaining aqueous phase was concentrated m a countvial and assaved for total 
radioactmtv 
The efficiency of the extraction was calculated for each sample and accounted 80 99 % 
of the total-radioactivity, depending e g on tissue and survival period 
Assay of radioactivity 
Radioactivity of aqueous liquids was counted after mixing with 1 о ml of о 75 M 
Soluene (Packard) and subsequent warming for 4^ mm at ,0° С After mixing with 
1S о ml of scintillation cocktail of ВЕ»АУ (i960) the counting was performed with a Nuclear 
Chicago, Mark I, or a Packard Tncarb 3380 AAA liquid scintillation counter Corrections 
were made by the external standard method 
Radioactive hands on TLC-plates were detected with a Desaga scanner (type 12-2) 
equipped with a Berthold Zahlratenmesser LB 2031, and were s\nchronouslv recorded 
Quantitation of the scans was performed by estimating peaksurfaces as the product 
of peak height, and the width at half height 
Spots and bands of intact cansoprodol were removed from the plates and suspended 
in 10 о ml of a scintillation cocktail containing 4 g PPC), о 250 g dimethyl-POPOP, 30 g 
Cab-O-Sil in 1 1 toluene and assaved The efficiency of this procedure accounted 95 00. 
Peak surfaces of the separated cansoprodol and meprobamate were correlated with 
the data obtained from hquid-scmtillation-counting of the cansoprodol spots 
С hromatography 
'Ihin-layer-chromatography on precoatcd TLC-plates, Silica Gel F 254 (Merck A G , 
Darmstadt, Germany) and a solvent system containing ethylacetate-n-hexane-ammonia 
(12 'Ό) (60 27 25) was used 
RESULTS 
General aspects of distribution of meprobamate, cansoprodol and tybamate 
A uniform distribution pattern of meprobamate was already reported 
by EW-ALDSSON (1963) and VAN DLR KLEIJN (1967) using 3 H - and 
1 4C-meprobamate respectively. In particular, at short periods after 
intravenous and oral administration it was noticed that brain, thymus and 
bodyfat showed the lowest concentration, compared to blood, lungs and 
skeletal muscles, while myocardium, liver, hypophysis and adrenal 
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cortex demonstrated a higher concentration. Fifteen minutes after ad­
ministration the earlier observed differences were completely balanced 
out ( F I G . I ) . A very slow penetration of meprobamate into the central 
WHOLE BODY AUTORADIOGRAPHY MICE 
MEPROBAMATE 
i.v. a d m i n i s t r a t i o n 
b r a i n brown fat p a n c r e a s 
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I I — = i Γ 1 
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t h mc Ы 1 
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t h Ы mc 1 
30 min 
F I G . I 
Autoradiograms of mice after i.v. injection of 1 4C-meprobamate. White area means 
presence of radioactivity. Notice the low concentration in the brain and the high con­
centration in blood, myocardium, kidney and cervical muscle at the 40 sec period, and 
the rather uniform distribution after 30 min. 
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F I G . 2 
Autoradiograms of mice after i.v. injection of 14C-carisoprodol. White area means 
presence of radioactivity. Notice the high uptake of radioactivity in several regions of 
the brain 40 sec after administration and the close similarity with the pattern of mepro-
bamate at the io min period. 
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nervous system was observed. The maximum concentration of radio­
activity in the brain was reached 10-15 гп^п after i.v. administration. 
However, carisoprodol and tybamate were rapidly taken up in the central 
•WHOLE BODY AUTORADIOGRAPHY MICE 
TYBAMATE 
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F I G . 3 
Autoradiograms of mice after i.v. injection of 1 4C-tybamate. White area means presence 
of radioactivity. Notice high uptake of radioactivity in several regions of the brain 50 sec 
after injection, and the close similarity with the pattern of meprobamate and carisoprodol 
at the io min period. 
WHOLE BODY AUTORADIOGRAPHY MICE 
MEPROBAMATE 
o r a l a d m i n i s t r a t i o n . 
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;^^»-_.,. 
5 min 
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F I G . 4 
Distribution of 1 4C-meprobamate in mice after oral administration. White area means 
presence of radioactivity. Notice the rapid absorption from the gastro-intestinal tract 
5 min after administration high concentrations are present in liver and kidney, but only 
low concentrations appear in the brain. After 30 min a rather uniform pattern can be 
observed. However, the brain shows a lower labeling than the blood, skeletal muscle etc. 
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nervous system. T h e concentration decay of radioactivity was very rapid 
as well, resulting in a similar distribution pat tern such as meprobamate , 
reached about 5 min after i.v. administration ( F I G . 2 and 3). 
After rectal administrat ion no differences in affinity of the central 
nervous system for the three compounds could be observed ( F I G . 6). 
WHOLE BODY AUTORADIOGRAPHY MOUSE 
MEPROBAMATE 
colon descend. 
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FIG. 5 
Distribution of I4C-meprobamate in a mouse 15 min after rectal administration. White 
area means presence of radioactivity. Notice the uniform distribution of radioactivity 
which is also demonstrated 15-30 min after i.v. and oral administration of meprobamate. 
Specific aspects of distribution of meprobamate, carisoprodol and tybamate. 
Central nervous system. 
T h e initial uptake of radioactive material differs greatly depending on 
the type of drug. A surprisingly low level of radioactivity was demon-
strated in the brain until i o min after i.v. administration of meprobamate . 
Carisoprodol and tybamate were very rapidly taken up by the strongly 
vascularized gray matter of cerebral and cerebellar cortex. U p to 5 min 
after injection high concentrations were found in cortex, h ippocampus, 
thalamus, inferior colliculi and spinal cord. After 5 min differences in the 
anatomical regions of the brain were leveled out. Distinct from ataractic 
drugs of the diazepine-group no retention of radioactivity in the white 
matter of the C N S and in the peripheral nerves could be demonstrated 
after longer survival periods [VAN DER K L E I J N , 1969 (1)]. 
T h e maximum concentration of meprobamate was reached 15 min 
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after injection. Slight differences between the various regions of the 
brain could be observed, but were soon balanced out. 
No variations could be distinguished anymore in the distribution of the 
radioactivity in the brain between the three different compounds 15 min 
after i.v. administration. The concentration of radioactivity at later 
survival periods was slightly lower than in the blood (FIG. I , 2, 3, 8). 
FIG. 6 
Distribution of 14C-meprobamate, 14C-carisoprodol and 14C-tybamate after rectal 
administration. White area means presence of radioactivity. No marked differences in 
general distribution can be observed. Only the concentration of radioactivity in the liver 
is higher after carisoprodol and tybamate treatment. 
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Cardiovascular system. 
The radioactive compounds were very rapidly taken up in the myocar­
dium. The labeling of the heart muscle rapidly decreases during the first 
10-15 т ' п after i-v· administration, but a slightly higher concentration 
than in the blood continued to be evident at all survival periods. 
The concentration of the compounds in the blood was high at the early 
periods, but fell rapidly during the first io min after i.v. injection.Qualita­
tively the concentration in the blood became equal to the concentrations 
in skeletal muscle, lung, brown fat, intestine, salivary gland and other 
organs. 
In the spleen no differences with the concentration in the blood nor 
between red and white pulp could be distinguished at all survival periods. 
Liver. 
The concentration of radioactive material accumulated during the first 
5 min after injection. At the io min period an incomplete circulation 
could be demonstrated in the pictures. The concentration of radioactivity 
in the liver was the highest of all organs. 
After 30 min accumulation of radioactive material in the bile and 
subsequent labeling of the lumen of the intestine could be demonstrated. 
Digestive system. 
At the early survival periods radioactivity rapidly appeared in the 
mucosal part of stomach and intestine. However, no excretion into the 
lumen could be noticed. 
After io min a rather uniform distribution was observed o\'er the whole 
gastrointestinal tract-wall. 
Eye. 
The eye rapidly accumulated the labeled material. Radioactivity due to 
the drugs was present in the choroidal layer. The decrease of radioactivity 
paralleled that of the blood. 
A high amount of radioactivity was present in the lachrymal glands at 
all survival periods. 
Endocrine glands. 
The hypophysis built up a high level of radioactivity immediately after 
i.v. administration and retained a higher level compared to the brain at 
all survival periods. 
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The adrenal cortex contained a higher amount of labeled material than 
the medulla at all survival periods. 
Urogenital system. 
The radioactive drugs were rapidly taken up by the ovaries after i.V. 
administration. The corpora lutea showed a higher amount of labeled 
material compared to the surrounding tissue. 
FIG. 7 
Distribution of meprobamate-, carisoprodol- and tybamate-14C in pregnant mice. 
White area means presence of radioactivity. Notice the similar distribution of radio-
activity in the foetus 30 min after injection in spite of the different initial patterns in 
the mother. 
The distribution pattern in the sexual organs of the male was rather 
uniform at all survival periods; labeled material appeared to be present in 
the interstitial tissue of the testis. 
The kidney showed a high labeling within 40 sec after administration. 
The concentration of radioactivity decreased parallel to that in the 
blood. After io min radioactivity appeared in the urinary bladder. 
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WHOLE BODY AUTORADIOGRAPHY MICE 
i.v. a d m i n i s t r a t i o n 
c e r e b e l l u m brown fat 
c e r e b r u m eerv muscle с cb cm 
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F I G . 8 
Detai ls of d i s t r ibut ion p a t t e r n s of urea-, m e p r o b a m a t e - , p h e n a z o n - , car i soprodol-
a n d t y b a m a t e - I 4 C after i n t r a v e n o u s a d m i n i s t r a t i o n . N o t i c e the differences in u p t a k e of 
t h e d r u g s in t h e centra l n e r v o u s sys tem at the early survival per iods . A l t h o u g h the per iods , 
after which m a x i m u m c o n c e n t r a t i o n in the bra in is reached, widely differ a great re­
semblance of t h e p a t t e r n s of radioactivity is observed, w h e n d i s t r ibut ion e q u i l i b r i u m is 
achieved. 
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Lungs; lymphatic tissue; skeletal muscle; skin. 
The radioactivity in the lungs, lymphatic tissue, skeletal muscle and 
skin did not differ from that in the blood during all survival periods. The 
uptake in the thymus was retarded compared to the other organs but after 
5 min no differences could be observed. At the early survival periods the 
cervical muscle was rather strongly labeled as compared to other muscles. 
WHOLE BODY AUTORADIOGRAPHY MICE 
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Details of d i s t r ibut ion p a t t e r n s of inul in- a n d h i g h m o l e c u l a r - d e x t r a n - l 4 C after i.v. 
a d m i n i s t r a t i o n . N o t i c e t h e differences in u p t a k e of radioactivity by skeletal musc le , 
g l a n d u l a r t issue and bodvfat. T h e d i s t r ibut ion of d e x t r a n is restr icted to t h e intravasal 
space. 
Adipose tissue. 
In contrast to meprobamate, carisoprodol and tybamate were rather 
rapidly taken up in adipose tissue, especially in the brown fat. After ю 
min the concentrations had been decreased to the level of blood and other 
tissues. 
Distribution of meprobamate, carisoprodol and tybamate in pregnant mice. 
The passage through the placenta was rather slow, 2 min after injection 
of either of the three compounds hardly any radioactivity could be 
detected in the foetus. After 15 min a uniform distribution of radio­
activity was present in the foetus at a level slightly lower than in the blood 
of the mother. 
After 30 min hardly any difference could be detected between the 
foetus and the mother. No differences were observed between the distri-
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bution patterns of radioactivity derived from the three different com-
pounds in the foetus (FIG. 7). 
Distribution of meprobamate after oral administration. 
Meprobamate was rapidly absorbed from the gastrointestinal tract 
following oral administration. 5 min after ingestion the distribution of the 
absorbed part of the dose was already rather uniform. Only very small 
FIG. 10 
Distribution patterns of meprobamate in the gastro-intestinal tract after administration 
in two different drug additives. Notice the swelling of the intestine caused by macrogol 300. 
amounts were present in the brain. Obviously the gastrointestinal tract 
showed the highest amount of radioactivity. The liver showed a high 
affinity for the drug after 30 min. Moreover at longer survival periods the 
uniform pattern, characteristic for distribution over total body water, 
could be demonstrated (FIG. 4). 
Since polysorbates were reported to have a retarding effect on ab-
sorption of drugs (LEVY and REUNING, 1964) correlated to micelle-
binding properties, the meprobamate was orally administered either 
solubilized in 10 % polysorbate 80 (Tween 80) or solved in 60 0 0 macro-
gol 300 (polyethyleneglycol 300). Autoradiograms, however, did not 
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show any correlation to the micelle-binding. Absorption of meprobamate 
appeared to be retarded when administered in macrogol 300 solution. 
Evidence is provided that binding to the solubilizing substance is of 
minor importance compared with the action of the additive itself on the 
gastro-intestinal tract. Experiments on the isolated guinea-pig ileum 
showed a papaverine-like spasmolytic action of polysorbate 80 and 
macrogol 300 in concentrations which could be expected after oral 
administration. Macrogol 300 is a hygroscopic substance; in mice it 
Fie. 11 
Concentration decay curve of carisoprodol in brain of mice. Notice the rapid initial 
elimination of carisoprodol and total radioactivity. Meprobamate-formation is the major 
metabolic pathway in mice. The penetration of meprobamate into the brain is slow as 
compared with the penetration in other tissue. Compare Figure 1. 
8ο 
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caused a swelling of the lumen of the intestine dur ing its passage and a 
pronounced diarrhoea ( F I G . I O ) . 
Distribution of meprobamate, carisoprodol and tybamate after rectal 
administration. 
M e p r o b a m a t e was administered either solved in a macrogol 4000, 
macrogol 11500 mixture (2 : 1 ) or mixed with Estar inum B. T h e absorption 
appeared to be faster from the macrogol m e d i u m than from the fat 
m e d i u m ( F I G . 5). 
^g/g lung , 
100 
10 
0 1 -
t o t a l - 1 4 С 
m e p r o b a m a t e 
carisoprodol 
20 60 80 40 
F I G . іг 
Concentration decay curve of carisoprodol-14C in lung of mice. According to the auto-
radiograms, concentration of radioactivity in lung is comparable with the concentration 
in blood. Notice the biphasic elimination pattern of carisoprodol. Meprobamate rapidly 
appears in the tissue. 
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No differences in the general distribution pattern between either 
meprobamate, carisoprodol or tybamate could be established (FIG. 6). 
The maximum concentrations were reached about 30 min after applica-
tion. No special affinity of the radioactive material for the brain could be 
demonstrated in this way. The absorption and dissolution rate of the 
drugs are limiting factors in the distribution of the substituted drugs 
since dealkylation is a very fast process in mice. The general distribution 
pattern of radioactive material 30 min after rectal administration was in 
0.1 -' 1 1 1 1 1 1 1 1 H 
20 40 60 80 m i n 
FIG. 13 
Concentration decay curve of carisoprodol-11C in liver of mice. In liver tissue next 
to meprobamate three other metabolites can be detected in minor concentrations. 
6 
82 E. VAN DER KLEIJN 
agreement with the pattern established following the other routes of 
administration. 
Metabolism of cansoprodol. 
From tissue analysis it could be concluded that carisoprodol is rapidly 
BRAIN 
6 m i n 
s e n s 100 
^ - ^ Л ^ А л Л ^ » 
E 5 
i ' c 
F E S 
LIVER 
6 m i n 
s e n s : 10O 
9 0 m i n 
s e n s : 100 M 
F E 
F I G . 14 
Distribution pattern of cansoprodol and metabolites in tissue-extracts after separation 
on TLC-plates io min after i.v. administration. In brain, lung and heart the same pattern 
can be distinguished. In liver at least four metabolites can be observed. 
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dealkylated into meprobamate. Other metabolites were present in minor 
quantities. Only in liver other peaks corresponding to radioactive meta-
bolites could be detected (FIG. I I , 12, 13). 
Hydroxylation of carisoprodol and meprobamate was found to yield the 
major metabolites in dogs (EDELSON et al., 1965). 
Although the separated peaks were not closely investigated, the 
metabolites were quantitatively not of special interest in the brain, heart 
and lungs (FIG. 14). Maximum concentration of radioactivity in the 
tissue homogenates was reached 1-3 min after injection. 
The concentration decay of carisoprodol in the tissue demonstrated a 
biphasic character, io min after administration the concentration of 
carisoprodol accounted for about 10 % of the maximum which is auto-
radiographically not detectable. The quantitative analysis data explain 
the great similarity of the autoradiograms of meprobamate and carisopro-
dol some 10 min after administration. 
DISCUSSION 
By qualitative comparison of the macroautoradiograms of mice which 
were given intravenously meprobamate, carisoprodol or tybamate, it 
appeared that lipid-solubility corresponding to partition coefficients and 
solubility in various solvents (DOUGLAS et al, 1964; VAN DER KLEIJN, 
1969) plays an important role in the rate of penetration of a drug into the 
brain tissue. Thus, uptake of meprobamate into the central nervous 
system was slow and slight, whereas carisoprodol and especially tybamate 
showed high central concentrations before 5 min after intravenous 
injection. 
In the distribution in the brain at short survival periods vascularity 
plays an important role. 
As a consequence inferior colliculi, cortex, thalamus, midbrain and 
hypothalamus showed the highest labeling (CASSANO et al., 1967; 
GOLDSTEIN et al., 1968). 
However, differences in the regional distribution between meproba-
mate, carisoprodol and tybamate can only be explained on the basis of 
lipophilic properties and tissue affinity. The generally retarded uptake of 
lipophilic drugs in adipose tissue was slightly demonstrated during a 
short period from 5-10 min after injection. Rapid metabolism, however, 
controlled the elimination of the parent drug. 
Dealkylation, hydroxylation and subsequent conjugation were reported 
as the main routes of biotransformation of drugs of the meprobamate-
group (DOUGLAS et al., 1962, 1963, 1966). 
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From tissue analysis of carisoprodol, quantitative differentiation of 
radioactivity demonstrated that after io min hardly any parent drug 
contributed to the observed autoradiographic pattern. Fig. i, 2, 3 and 8 
demonstrate the great resemblance of the patterns of radioactive material 
due to meprobamate and homologues after 10-30 min with the pattern of 
urea after 1 hour. This comparison leads to the conclusion that mepro-
bamate and the metabolites of carisoprodol and likely tybamate are 
distributed over the total body water space. 
Data of BERGER et al., 1959 and of BERGER et al., 1964 of paralysing 
activity and acute mortality, demonstrating a trend of increased toxicity 
and activity in the sequence of meprobamate, carisoprodol and tybamate 
after intravenous administration, can be explained on basis of penetration 
rate into the brain. The minor differences in toxicity and activity after 
oral administration agree with the autoradiographic and analytical 
data. 
Biotransformation competes with the absorption process. The rate of 
metabolite appearance or metabolite formation is greater than the 
absorption rate. 
Only when absorption rate is much higher than the rate of elimination 
enteral administration may demonstrate the observed differences in 
pharmacological properties. 
Although these distribution studies give no correlation with the 
different shades in pharmacological action on the central nervous system 
it can be concluded that the faster penetration into the brain and fatty 
tissues in the body after i.v. administration can be explained by the 
increased lipophilic nature of the drugs. 
The slow and slight penetration of meprobamate into the central 
nervous system lead to the comparison of the distribution patterns of the 
ataractic drugs with those of body-volume indicators. 
Macroautoradiography, in general, does not enable the quantitative 
analysis of tissue concentrations. 
From Fig. 8 it appears that there is a great similarity between the 
distribution of urea and meprobamate. Differences concern the time 
course in which the maximum brain concentration is reached. 
Phenazon (antipyrine) penetrates more rapidly into the central nervous 
system. The rate of penetration of the compounds into the brain corre-
sponds with the physicochemical properties expressed as solubility in 
water and in chloroform, as partition coefficients between chloroform 
and water and as Rf-value on T.L.C. (TABLE II). 
High lipid-solubility, partition coefficient and Rf value parallels rapid 
penetration into the brain. 
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T A B L E II 
Solubility 
ι g/x g solvent 
chloroform water 
Partition 
Coefficient 
chloroform-water i1)' 
R/-value χ 100 
chloroform-aceton 
UREA 
MEPROBAMATE 
PHENAZON 
CARISOPRODOL 
TYBAMATE 
0 
2 0 0 
I 
1-9 
o.S 
I 
300 
I (>) 
2050 
4100 
3-3 
28 (») 
4 0 0 
>5°o I 
2 
19 
32 
55 
56 
(') Data of VAN DER K L E Y N 1969 (2). 
(2) Data of BRODIE (1964). 
(3) Data of MARTINDALE, Extra Pharmacopoeia, R. G. T o d d (ed.), T h e Pharmaceutical 
Press, London. 
The urea and phenazon patterns are model for the distribution in total-
body water although each of them show their own specific properties. 
Body fluid compartments are classified as total body water 61 %, which 
is built up by intracellular water (34 %) and extracellular water (27 % ) . 
Of the extracellular water 15 % is the physiologically active part. 
Of this 4 % is the plasma-water and 1 1 % the fast exchangeable 
interstitial water (MERZ, 1962). 
The great volume variations between these intravasal, extracellular and 
total body water spaces enable a qualitative distinction of the distribution 
of drugs. Inulin (MW 5000-5500) is distributed over the physiologically 
active extracellular water and the distribution of dextran (MW 60.000-
90.000) is restricted to the intravasal space, although little will leak to the 
extracellular space ( F I G . 9). The distribution of inulin in e.g. skeletal 
muscle, myocardium and salivary gland is slight and in the pattern of 
dextran, radioactivity can predominantly be demonstrated in the blood­
vessels. 
CONCLUSIONS 
Comparative investigations on the distribution of ataractics of the 
meprobamate-group in mice demonstrated that differences in lipophilic 
nature of the homologues resulted in variations in initial penetration rate 
of the drugs into the brain. Rapid metabolic conversion is considered as 
the reason that these variations cannot be demonstrated after enteral 
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administration of the compounds. The slow transfer through the placenta 
inhibited the uptake of the parent drug by the foetus. 
SUMMARY 
The kinetics of distribution and metabolism of meprobamate, cariso-
prodol and tybamate were studied in mice following different routes of 
administration, according to the "whole body" autoradiographic techni­
que of Ullberg (1954, 1958). The rapid penetration into the brain as 
observed for the homologues of meprobamate after intravenous admi­
nistration at short survival periods can be correlated with the higher lipid 
solubility. A great resemblance of the pattern of the various compounds 
could already be observed io min after injection. Rapid biotransformation 
of carisoprodol in mice was established by analysis of tissue-extracts. 
Meprobamate was found to be the major metabolite in mice. Following 
rectal administration no mutual differences in distribution pattern could 
be noticed. 
In pregnant mice a slow penetration of the drugs through the placenta 
was observed. Radioactivity was uniformly distributed in the foetus. 
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CHAPTER V 
KINETICS OF DISTRIBUTION AND METABOLISM OF 
DIAZEPAM AND CHLORDIAZEPOXIDE IN MICE 
INTRODUCTION 
Since the introduction of chlordiazepoxide (Librium11) in the treat-
ment of anxiety and psychic tensions, 5-phenyl-i,4-benzodiazepines 
have been shown to be of great value in an increasingly wide area of 
therapeutic application. 
Diazepam (Valium11) related to chlordiazepoxide in chemical struc-
ture and pharmacological actions is now preferred by many clinicians as 
the best anti-anxiety drug at present available and by its muscle relaxant 
properties. 
Although there is an enormous amount of literature available concern-
ing the clinical and experimental applications of the diazepines, only 
relatively few investigations on the distribution of diazepam, chlor-
diazepoxide and its metabolites in the body have been reported. 
The metabolism of diazepam has been studied in animals and man. 
N^desmethylation, Cg-hydroxylation of the parent compound and 
conjugation of the hydroxylated products have been demonstrated as the 
major metabolic pathways in man, dog and mouse (DE SILVA et al., 
1964; RuELius et al., 1965; SCHWARTZetai , 1965; DE SILVA etal, 1966; 
KVETINA et al., 1968). Para-hydroxylation of the 5-phenyl-ring was re-
ported by JOMMi et al. (1964) for rabbit and proved by SCHWARTZ et al. 
(1967) for rat. 
Differences in physico-chemical properties are used to explain the 
differences in pharmacokinetics of structure-related compounds (MAYER 
etal., 1959; BRODIE et al. i960; CASSANO et ah, 1967; HESS et al., 1968; 
VAN DER KLEIJN, 1968). 
The purpose of this investigation was to study the distribution of 
diazepam and chlordiazepoxide in mice at different survival periods, 
following different routes of administration. 
Metabolism of diazepam was studied and differences in distribution 
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patterns were correlated to physico-chemical properties of the drugs and 
metabolites. 
MATERULS AND METHODS 
Radioactive compounds: 
"C-diazepam and 14C-chlordiazepoxidc were generously supplied by Hoffmann-La 
Roche, Basle, Switzerland. The compounds were labeled m position 2 and had a specific 
activity of 12.3 /iC/mg and 39.8 ¿iC,'mg respectively. 
The chemical and radio-chemical purity of the compounds were checked by thin-layer 
chromatography in heptane-chloroform-ethanol (5:5:1) and by subsequent scanning with 
a Desaga-scanner type (12-2). Both labeled diazepam and chlordiazepoxide appeared to 
contain less than 2 pCt impurities. 
Since 14C-chlordiazepoxidc is partially transformed by ^-irradiation and davlight into 
the Nj-Cs-epoxide derivative, the compound was used immediately after delivery. Thin-
layer chromatography is reported not to be useful to separate chlordiazepoxide from its 
epoxide derivative (KOFCHI.IN et al., 1965). 
a) Autoradiography. 
Adult, male Swiss mice (average weight 20-22 g) and pregnant female mice two days 
before delivery (bodyweight about 40 g) were used. 
Of diazepam and chlordiazepoxide 15 mg (200 f¿C)/kg was given intravenously (i.v ) 
and 30 mg (zoo /iC)/kg was given orally. 
The compounds were dissolved in dichlormethane containing polysorbate 80. The 
solvent was evaporated and the residue solubilizcd in 0.9 no NaCl-solution. The final 
polysorbate-conccntration was 2 "Ό- The mice received 0.01 ml/g bodyweight. Imme­
diately before sacrificing the mice were lightly anaesthetised with halothane and rapidly 
frozen by immersion in isopentanc cooled to about —yo'C with solid carbon dioxide 
After i.v. injection survival periods of 14", 50", 60", 2', 5', 10', 15', 30', 45', 60', 2 h, 
4 h, 6 h, 7 h, 16 h, 24 h were used in male mice, while in pregnant mice sur\ival periods 
of ' Ι 3> 5> I O 1 I 5 ' . 3° > 6ο', 2 h, 4 h and 15 h were used; after oral administration 
sur\ival times of 5', 15', 30', 60', 90', 2 h, 3 h, 4 h, 7 h and 24 h were used 
Autoradiographic technique according to Ullbcrg (1954, 1958) was used. The frozen 
animals were embedded in cooled carboxymethylcellulose (5 "„) solution, and rapidly 
frozen in solid carbon dioxide. Sagittal sections, 30 μ thick simultaneously through two 
animals were made in a refrigerated room (temperature about — I2 1C) with an hydraulic 
driven Leitz-sledgc microtome 1300. After adhering to Scotch Tape (Permanent 
Mending Tape No. 810, 3 M Co., U.S A.) the sections were frceze-dricd and pressed on 
to Structunx (Gevaert) D 7 X-ray films and exposed for 15-25 days at — 12'C 
b) Chromatography. 
Thin-layer chromatography on precoated TLC-platcs, Silica Gel F 254 (Merck A G., 
Darmstadt, Germany) was done while the following solvent systems were used : 
1. Heptane-chloroform-ethanol (5:5:1). 
2. Benzene-ethanol (96 αό) (8.5.1.5). 
3. Chloroform-ethanol (abs.) (9:1). 
In order to improve separation TLC-plates were developed three times successively. 
Tissue analysis. 
Male S\MSS mice, previously starved for 24 hours, were injected intravenously in the tail 
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vein with diazepam (27 2 mg (340 jiC/kg), and killed 1', 5', io', 15 , -jo', 45', 60', 2 and 
4 h after administration The brains, hearts and li\ers were removed and weighed and 
subsequently homogenized with an Ultra-Turrax T P 18/2, in 2 vol of а о s M phosphate 
bufler (pH — 6 8), containing ο ι "„ KCN The tubes and homogenizer were rinsed 
The decanted homogenates and rinsing fluids of each sample were collected and made up 
to 10 о ml r 00 ml of homogenate was transferred into a countvial and assaved for total 
radioactivity The remaining portion of the tissue homogenates was transferred into 40 ml 
tubes and extracted twice with 10 ml of ethvlacetate The organic phases were collected 
and evaporated The residues were transferred quantitatively to thin-layer chromatography 
plates and developed once in solvent 2 and subsequently twice in solvent 3 
The efficiency of the extraction accounted for 60 0 0 of the total radioactivity 
L'rme analysis 
Urine pooled from animals used in the autoradiographic experiments was extracted 
with ethvlacetate and the ethylacetate-residues were transferred to thin-lav er chromato­
graphy plates for identification These plates were chromatographed three times suc-
ccssivelv in solvent 3 
Assay of radwactibity 
The radioactivitv of the homogenates was counted after mixing with 1 о ml of о 75 M 
Soluene" (Packard) and warming for 45 mm at so r C After subsequent mixing with 
ι ς о ml of scintillation cocktail of Bray (i960) the counting was performed with a Nuclear 
Chicago, Mark I, liquid scintillation counter Corrections were made bv the external 
standard method 
Radioactive bands on TLC-plates were detected with a Desaga scanner (type 12-2) 
equipped with a Berthold Zahlratenmesser LB 2031 and synchronously recorded 
Quantitation of the scans was performed by estimating peak areas as the product of 
peak height, and width at half height 
Spots and bands of intact diazepam were removed from the plates and suspended in 
10 о ml of a scintillation cocktail containing 4 g PPO, 0250 g dimethyl-POPOP, 30 g 
CAB-O-SIL in 1 L toluene and assayed 
Peak-areas of the separated diazepam and dérivâtes were correlated with the data 
obtained from hquid-scintillation-counting of the dia/epam-spots 
The efficicncv of the TLC-procedure accounted for 95 6 0o The efficiency of the 
total procedure of extraction, spotting, developing, scraping and scanning was <;7 0( l 
RESULTS 
Whole-body autoradiography following intravenous and 
oral administration 
The uptake of radioactive diazepam in the brain was already very high, 
14 sec. after i.v. injection, while the uptake of chlordiazepoxide was 
slightly lower. Survival periods shorter than 14 sec. could not be studied. 
At the early survival periods extremely high concentrations of radio-
activity were found in myocardium, cervical muscle, adrenal and kidney 
WHOLE BODY AUTORADIOGRAPHY 
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FIG. I 
Autoradiograms showing the distribution of 14C-diazepam and radioactive metabolites 
in mice after i.v. injection of 15 mg (200 /j.C)/kg. 
White areas in the autoradiograms correspond to high activity. A very rapid uptake in 
CNS, kidney, adrenal, stomach wall, cervical muscle and myocardium can be observed. 
A low concentration is detectable in the blood. The liver and the bodyfat show an 
increasing concentration of radioactivity during the first 5 min. period. The gastro-
intestinal tract shows an increasing amount of radioactivity at all survival periods after 
5 min. after injection. 
WHOLE BODY AUTORADIOGRAPHY 
CHLORDIAZEPOXIDE 
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FlG. 2 
Autoradiograms showing the distribution of 14C-chlordiazepoxide and radioactive 
metabolites in mice after i.v. injection of 15 mg (200 μC)¡kg. 
White areas in the autoradiograms correspond to high activity. The radioactive material 
is rapidly taken up by the adrenal, kidney, cervical muscle, stomach wall and myocardium. 
The liver and the brain show an increasing concentration of radioactivity during the 
first 5 min. period. The gastro-intestinal tract shows an increasing amount of radioactivity 
at all survival periods after 5 min. after injection. 
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after administration of diazepam or chlordiazepoxide. The liver showed 
a spotted pattern, till 2 min. after i.v. injection. In the first periods after 
administration vascularity and affinity for the drug play an important 
role in the uptake of the radioactive labeled drugs by the different organs 
and tissues (FIGS, I and 2). 
From 3-30 min. after i.v. administration a high and constant level of 
radioactivity was present in the liver, kidney, salivary and lachrymal 
W H O L E BODY AUTORADIOGRAPHY M I C E 
DIAZEPAM 
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F I G . 3 
Autoradiograms showing the distribution of 14C-diazepam after oral administration of 
30 mg (200 μΟ)/1^. Note the high uptake of diazepam in the brain, heart, adipose tissue 
and liver at 30 min. after administration. 
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glands, heart and skeletal muscle, great vesselwalls and adrenal cortex. 
The initial labeling of different regions in the brain was leveled out. 
A different distribution pattern in the brain occurred after 30. min. 
From 30 min.-4 h after administration there was a slow decrease in the 
concentration of radioactivity in all organs. The concentration decay of 
radioactivity was faster in the case of chlordiazepoxide than of diazepam. 
The ratio between the concentrations of radioactivity in brain and blood 
was higher after i.v. and oral administration of diazepam than after 
similar administration of chlordiazepoxide at each survival period respec-
tively as could be measured densitometrically. 
The concentration of radioactivity derived from diazepam fell only 
slightly during the first 4 h period in all organs and rose in the gastro-
intestinal tract, while after 24 hours only small amounts of the drugs 
were detectable in the excretory organs, the peripheral nerves and the 
nasal cavity. 
The general pattern of distribution at 2 h following oral administration 
of diazepam or chlordiazepoxide was similar to that seen after i.v. in-
jection ( F I G . 3). At shorter survival periods obviously phase differences 
due to the absorption process could be detected. 5 Min. after oral ad-
ministration the brain and especially the gray matter demonstrated its 
high affinity for both drugs. This affinity was more pronounced in the 
case of diazepam than in the case of chlordiazepoxide. 
Accumulation of the drugs in the brain, liver, muscles, heart and 
kidney was progressive and reached a maximum some 1-2 hours after 
oral administration. 
Retention of labeled material was observed likewise in the white mat-
ter of the central nervous system after 4 hours. 
15 Min. after ingestion labeled diazepam appeared in the adipose 
tissue. The maximum concentration was reached in 1 hour and 
decreased rapidly there after. 
Specific aspects of distribution of diazepam 
and chlordiazepoxide 
Central nervous system : 
Since diazepines are considered to affect specific functions of the 
central nervous system, a detailed investigation of the distribution of the 
drugs throughout the brain was desirable. 
After i.v. administration there is a rapid uptake of radioactivity by the 
gray matter of the cerebral and the cerebellar cortex, especially the 
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colliculi and the thalamic and medullar nuclei. The uptake of diazepam 
into the brain was somewhat faster than that of chlordiazepoxide. 
The concentration of 14C-diazepam reached its maximum in about 
ι min. after i.v. injection., whereas the uptake of 14C-chlordiazepoxide 
increased progressively for 5 min. after administration ( F I G . 4 and 5). 
From 5-30 min. the predominant labeling of the gray matter by both 
compounds has become equivalent over the whole brain, whereas after 
30 min., selective retention of radioactivity started in the white matter 
F I G . 4 
Details of autoradiograms showing the distribution of 14C-diazepam and radioactive 
metabolites in mice. Note the high uptake of radioactivity 1 min. after i.V. injection in 
the cortex of cerebrum and cerebellum in the colliculi and in the thalamic and medullar 
nuclei. The labeling of the adipose tissue is typical for diazepam. After 7 hours the 
concentration in the brain is equaled. Retention in the white matter and peripheral 
nerves can be observed. 
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especially that of the corpus callosum, midbrain, cerebellum and spinal 
cord. Radioactivity was detectable in the peripheral nerves : the trige-
minal, optic and spinal nerves, for up to 24 h after administration. 
The distribution patterns of radioactivity throughout the anatomically 
corresponding regions of the brain were similar for both compounds, 
although loss of radioactivity derived from chlordiazepoxide was faster 
than that from diazepam. 
WHOLE BODY AUTORADIOGRAPHY 
CHLORDIAZEPOXIDE 
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FIG. 5 
Details of autoradiograms showing the distribution of 14C-chlordiazepoxide and 
radioactive metabolites in mice. Note the selective uptake of radioactivity 5 min. after i.v. 
administration in the colliculi and the thalamic and medullar nuclei of the brain. No 
labeling of the adipose tissue can be observed. After 6 hours the radioactivity is retained 
in the peripheral nerves e.g. the trigeminal and optic nerve. 
7 
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Cardiovascular system. 
The labeled compounds were taken up very rapidly by the myocar-
dium. Indeed, the heart muscle and great vessel walls showed a very high 
concentration of radioactivity within 14 sec. after i.v. injection. The high 
concentration of radioactivity remained over the six hour period after 
which a gradual decrease was demonstrated. 
In the spleen no differences were observed between the labeling of the 
white and red pulp. The concentration of radioactivity in the spleen was 
somewhat higher than in the blood at all survival periods. 
Liver. 
The liver showed a spotted pattern characteristic of other lipophilic 
compounds at short periods after i.v. injection (CASSANO et al., 1967; 
CASSANO and HANSSON, 1966). 
During the first 5 min. a progressive increase of labeling was observed. 
After 5 min. the labeling remained extremely high and a slow decrease 
could be demonstrated after 6 hours. 
Digestive system. 
1 Min. after i.v. injection the mucosal wall of the stomach showed a high 
amount of radioactivity. 9 Min. later the contents of the stomach were 
strongly labeled indicating an abundant excretion of radioactivity into 
the lumen. Although the mucosa of the proximal as well as the distal part 
of the small intestine and coecum, colon and rectum were labeled more 
strongly than the serosa no excretion into the lumen of the gut was 
demonstrated. 
From 30 min. after injection the lumen of the intestine contained 
increasing amounts of radioactivity. Most probably this radioactivity 
originates from the excretes of stomach and bile. 
The experiments with oral administration of diazepam and chlor-
diazepoxide to mice demonstrated that the drugs only slowly absorb from 
the intestine. It is probable that this phenomenon also occurs in man 
and dog since it has been demonstrated that maximum blood concentra-
tions are not obtained until 1-2 hours after oral administration (DE SILVA 
et al., 1966, GARATTINI, 1968; VAN DER KLEIJN, 1969). 
The absorption as well as the reabsorption of the drug will be discussed 
in the latter part of this paper. 
Eye. 
The eye rapidly accumulated the labeled material. Radioactivity due 
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to both drugs was detectable for several hours especially in the choroidal 
layer. 
The labeling of the trigeminal and optic nerve has been already 
reported under CNS. This pattern of labeling is not specific to the 
diazepines since other strongly lipophilic drugs show the same phe-
nomenon (CASSANO and HANSSON, 1966). 
A high amount of radioactivity was present in the lachrymal glands and 
it is possible that lachrymal secretion contributes to the labeling of the 
nasal cavity and subsequently of the stomach. 
Endocrine glands. 
The pituitary built up a high level of radioactivity which commenced 
1 min. after i.V. injection, and lasted no longer than 15 min. 
The adrenal cortex contained more labeled drug than the medulla at 
all survival periods. 
Urogenital system. 
The radioactive drugs were rapidly taken up by the ovaries. The cor-
pora lutea showed a high amount of labeled material during 6 hours 
after i.v. administration. 
The uptake of radioactivity by the sexual organs of the male was not of 
special interest. A rather low and uniform distribution was observed. 
However, in the testicle a net structure, not specific for the diazepines 
could be observed. 
The kidney showed a high labeling already during the early survival 
periods. The concentration of radioactivity decreased slowly over the 
next hours. After 5 min. radioactivity could already be observed in the 
urine bladder. 
Lungs. 
The radioactivity in the lungs was somewhat higher than that present 
in the blood, but comparable to that found in skeletal muscle, spleen and 
pancreas. 
Lymphatic tissue. 
In the lymph nodes and thymus a slow and slight accumulation of 
radioactivity could be demonstrated. 
Skin. 
Both compounds were taken up by the skin at a moderate rate. From 
5 min. after i.v. administration high concentrations were noted in the 
hair folliculi. 
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Adipose tissue. 
In contrast to chlordiazepoxide, diazepam was highly taken up in the 
brown fat as well as the perirenal and the epididymal fat. This is in agree-
ment with recent findings of MARCUCCI et al. (1968 b). Although little 
radioactivity was present before 2 min., after i.v. injection, the uptake 
proceeded progressively for 30 min. After that period, the radioactivity 
fell more rapidly from adipose tissue than from the other organs. This 
indicates the removal of the original drug rather than the metabolites. 
After oral administration labeling of the body fat appeared within 
15 min., but had almost disappeared after 2 hours. 
Skeletal muscle. 
The labeling of the muscle was built up slowly from the moment of 
injection till io min. later. This may be due to the relatively poor blood 
supply of muscle at rest and the rather low affinity of the tissue for the 
drugs. In contrast the cervical muscle already showed a high labeling 
1 min. after i.v. injection. After io min. a rather constant level of radio-
activity was observed in the muscles, which remained higher than that 
observed in blood. 
Distribution of diazepam in pregnant mice 
The passage of the drug through the placenta was slow and slight. 
After 15 min. a low amount of radioactivity appeared in the foetus. The 
maximum concentration was reached 2 hours after the i.v. administration. 
The distribution of the labeled material in the foetus was rather uni-
form. The concentrations in corresponding tissues were lower in the 
foetus than in the mother at all survival periods. The liver of the foetus 
did not take up a high amount of radioactivity but the brown fat and the 
mucosa of the gastrointestinal tract contained a surprisingly high amount 
some 30 min. after injection (FIG. 6). 
A considerable amount of radioactivity was still present in the foetus 
after 4 hours. However, the concentration remained lower than that 
present in the mother. After 15 hours radioactivity had almost disap-
peared from the foetus. At that time radioactivity could still be observed 
in the mother. 
Metabolism of diazepam 
From tissue analysis it could be concluded that diazepam is rapidly 
metabolized into several compounds detectable by their 14C-label(FIGS. 
FIG. 6 
Autoradiograms showing the distribution of "C-diazepam and radioactive metabolites 
at various survival periods in pregnant mice. Note the slow and slight uptake of radio-
activity into the foetus. At later survival periods the highest amounts of radioactivity in 
the foetus are found in liver, bodyfat and gastrointestinal tract. 
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7, 8 and 9). Diazepam (1), oxydiazepam (2), desmethyldiazepam (3) 
and oxazepam (5) could be identified by the Rt-valucs of their reference 
compounds. Other metabolites were not identified structurally, but were 
reported by SCHWARTZ et al. (1967). Desmethyldiazepam was found to be 
the major metabolite in heart and brain, while oxydiazepam and oxazc-
>ig/j brain 
Kinetics of metabolism and elimination of diazepam in brains of mice. 
Concentration-time curve of total radioactivity expressed as /ig diazepam/g tissue 
( О ν ;) and of diazepam ( " : ) and its main metabolites, Χ,-desmethyldiazepam 
( Δ Δ) and oxazepam ( · · ) . Other metabolites are present only in minor 
quantities (see F I G . I I ) . 
pam were found only in minor quantities. It may be concluded that 
desmethyldiazepam and the other metabolites are more slowly eliminated 
than the parent drug. However, in rat tissue desmethyldiazepam is 
detectable only in minor quantities (GARATTIN'I, 1968). 
This indicates that different species have different rates of formation 
and elimination of metabolites. In man, desmethyldiazepam and 
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oxazepam appear only slowly in plasma while the rate of elimination of 
desmethyldiazcpam is about equal to that of diazepam (DE SILVA et al., 
1 9 6 6 ; G A R A T T I N I , 1 9 6 8 ; V A N DER K L E I J N , 1969) . 
In urine, hardly any original drug, minor quantities of desmethyl-
diazepam and oxydiazepam and large amounts of oxazepam and an 
^g/g hear t 
100 
Fio. 8 
Kinetics of metabolism and elimination oj diazepam in hearts of mice. 
Concentration-time curve of total radioactmty expressed as μg diazepam/g tissue 
( 3 C) and of diazepam ( j ) and its main metabolites, Ν,-desmcthyldiazepam 
( Д Δ) , oxazepam ( · · ) and one or more unknown metabolites of high polarity 
( A A) analysed in ethylacetatc extracts of tissue homogenates. Other metabolites 
are present in minor quantities. 
unknown metabolite (6) were detected. Closer examination of the area on 
the chromatogram between peak 4 and 5 and between 6 and 8 indicated 
the presence of four other unknown metabolites. In urine eleven radio­
active metabolites could be separated ( F I G . 10). 
From figures 7 and 8 it appears that the elimination of diazepam has a 
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biphasic nature. The rate of elimination can be characterized by the half-
life time (i j) or by the time constant τ [τ = 1.44 χ ί | ] . The rate of 
appearance of the metabolites in the tissue can also be characterized by τ 
and is assumed to be correlated with the rate of metabolism. 
jug/g Iivei ι 
100 η I 
Kinetics of metabolism and elimination of diazepam in liver of mice. 
Concentration-time curve of total radioactivity expressed as fig diazepam g tissue 
( О О) and of diazepam ( " Z¡) and its main metabolites, Ni-desmethyldia/epam 
( Δ Δ) and oxazepam ( · · ) Other metabolites are present only in minor 
quantities. The relative amounts of diazepam and its metabolites present in the liver 
differ from the pattern present in heart and brain 
Oxazepam reaches higher concentrations than in figures 7 and 8. From the pictures 
7, 8 and g it can be concluded that in mice Ν,-desmethylation of diazepam is a much 
faster process than C2-hydrox> latum. 
To estimate t\ of the initial parts of the elimination curves of diazepam 
and the appearance curves of the metabolites use is made of the residual 
plot method (SOLOMON, i960). From Table I it appears that the initial 
elimination of diazepam is very rapid. In this phase distribution of the 
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URINE MICE 
24 h sens . . 300 
E S 
Fie. io 
Radioscan of an ethylacetate extract of pooled urine of mice treated with nC-diazepam. 
A trace amount of the parent compound is recovered. Oxazepam (5) and an unknown 
metabolite (6) are found in relatively high concentrations. 
Seven metabolites are detectable in the extracts. T L C was earned out successively in 
solvent 2.2 and 2. 
Closer analvsis of the area between 4 and 5, and between 6 and 8 yielded four other 
metabolites ( X ). 
TABLE I 
τ = 1.44 x ' i mm. 
Brain 
Heart 
Diazepam 
Liver 
68 
57 
Desmethyldiazcpam 
21 1 
17 
23 
> 240 
> 240 
± 80 
Oxazepam 
76 
26 
16 
> 240 
2 4 0 
2 4 0 
Table summarizing some kinetic parameters of metabolism and elimination of diazepam 
in mice calculated from the curves in the figures 7, 8 and 9 according to the residual plot 
method (Solomon, i960). The time constants of appearance of the metabolites in the 
tissue are supposed to be equal to the time constant of metabolite formation. The elimina­
tion of diazepam occurs in two phases. The first phase parallels the formation of the 
metabolites. The second phase is supposed to be highly controlled by the reabsorption 
process. T! = time constant of elimination process, first phase. τ 2 — time constant of 
elimination process, second phase. т1ш — time constant of metabolite formation process. 
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drug over a large apparent distribution volume takes place and rapid 
metabolism greatly controls the elimination of the parent drug. The 
elimination rate of the two most important metabolites in mice is much 
lower than that of diazepam. 
In the liver concentrations of the metabolites are different from those in 
the heart and brain. This might indicate that the liver is the main locus of 
metabolism. 
The reduced lipophilic nature of the desmcthylated and hydroxylated 
compounds makes the presence of these compounds in the brain not 
impossible ( T I G . I I ) . It appears that the pattern of radioactivity can 
only partly be due to the radiation of the original compound. After ι hour 
only about io % of the radioactivity is present as diazepam. 
BRAIN MICE 
1 min sens 300 
30 mm ьепк 100 
J v _ ^ 
F I G . I I 
Some characteristic radioscans of brain extracts demonstrating the ethylacetate-
extractable radioactivity. At least seven metabolites can be detected. 
Diazepam (i), oxydiazepam (2), ΝΊ-desmethyldiazepam (3) and oxazepam (5) are 
identified by Revalues of the reference compounds. 
Metabolism of diazepam causes the formation of compounds with lower Revalues than 
the parent compound. T L C was carried out successively in solvent 2, 3 and 3. 
E = edge of plate; S =• start; F — solvent front. 
DISCUSSION 
Comparison of the autoradiograms after i.v. and oral administration at 
successive survival periods is useful although tissue analysis has made 
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clear that C2-14C-diazepam and C2-14C-chlordiazepoxide are rapidly 
converted into compounds still containing radioactive label. 3-Hydro-
xylation an N1-desmethylation is reported not to result in significant 
pharmacological inactivation but in decreased activity and toxicity 
(MARCUCCI et al., 1968 a). So the pictures continue to be representative 
for the distribution of the ataractic substance. 
Although no great differences in pharmacological effect between diaze-
pam and chlordiazepoxide could be observed visually in mice, it appeared 
from our autoradiograms that in the case of diazepam a faster penetration 
into the brain than of chlordiazepoxide could be demonstrated. This 
observation is plausible since diazepam has a stronger lipophilic nature 
than chlordiazepoxide (VAN DER KLEIJN, 1969). 
Recently PLACIDI and CASSANO (1968) published whole-body auto-
radiographic studies on chlordiazepoxide. From their pictures a more 
rapid accumulation of the drug in the brain could be demonstrated. 
Differences in dose of radioactive material may be the cause of this 
discrepancy. 
The distribution in the brain is evidently of special interest. The high 
concentration of diazepam and chlordiazepoxide in brain cortex, thala-
mus and brainstem of the mice may explain the initial narcotic and 
paralysing effect which last for about 3-5 min. After recovery no special 
inhibited behaviour of the mice could be observed visually. After 45 min. 
and more pronounced at later survival periods more detailed differences 
in the brain pattern of radioactivity were found. 
The white matter, especially of the spinal cord, of cerebellum and 
cerebrum, in the corpus callosum, brainstem and the peripheral nerves, 
e.g. the trigeminal and optic nerves, was stronger labeled than the sur-
rounding tissue. It is unlikely that unchanged diazepam will contribute 
to this detailed labeling to a considerable extent since one hour after 
administration about 90 % of the original drug is converted into at least 
seven metabolites of which desmethyldiazepam is the most important one 
( F I G . 7). 
The weak basic and lipophilic properties of chlordiazepoxide, diaze-
pam and their metabolites may explain the abundant excretion of the 
drugs into the strongly acid lumen of the stomach in agreement to the 
pH-partition theory (BRODIE, 1964). 
The enteric circulation of the drug with contribution of excretions 
from the nasal cavity, stomach, bile and possibly intestinal glands caused 
a rapid inflow of radioactivity into the gastro-intestinal tract. The strong 
binding nature of the compounds to proteins and other macromolecules 
may indicate that the drugs can be bound to elements of the intestine. 
io8 E. VAN DER KLEIJN 
The presence of radioactivity in the mucosa of stomach and intestine of 
the foetus starting about 30 min. after administration of the drug may 
confirm this. 
These phenomena may cause a slow and sustained absorption of the 
drug from the intestine. Pharmacokinetic data of chlordiazepoxidc and 
diazepam in man and dog indicate a reaching of the maximal blood-
concentration not before 1-2 hours after administration (KOECHLIN and 
d'ARCONTE, 1963; DESILVA et al., 1964; KOECHLIN étal., 1965; SCHWARTZ 
étal, 1965; DE SILVA et ai, 1966; GARATTINI, 1968; VAN DER KLEIJN, 1969). 
Since metabolic transformation only gradually affects the psychopharma-
cological properties the absorption process may contribute to a prolonged 
time course of action of diazepam and chlordiazepoxidc. 
The difference in distribution in adipose tissue between diazepam and 
chlordiazepoxidc can also be explained by the differences in lipophilic 
nature. The high accumulation of radioactivity in the brown and white 
fat of mice and of foetus after i.v. injection as well as after oral adminis-
tration of diazepam at relatively short survival periods and the rapid re-
moval at later periods do suggest that this accumulation predominantly 
is caused by intact diazepam more than by its metabolites. 
The spotted pattern of the liver at the early survival periods after i.v. 
injection may be explained by the fact that only the arterial circulation 
contributes to the pattern and that the portal circulation causes a phase 
difference. 
The high affinity of the liver for diazepam may be involved in the effect 
of the drug on the bromosulphophthalein liver test in vitro (KVETINA et 
al., 1968). 
The accumulation and long retention of radioactivity in the liver might 
suggest an induction of drug-metabolizing enzymes on the liver micro-
somes by diazepam that have been reported for chlordiazepoxidc 
(HOOGLAND et al., 1966). 
Although from electrophysiological experiments conclusions have been 
drawn concerning the site of central depressant action (PRZYBYLA and 
WANG, 1968), the distribution pattern in the brain after different survival 
periods is insufficient to explain these data. 
SUMMARY 
The distribution of intravenously and orally administered 1 ,C-dia-
zepam and 14C-chlordiazepoxide was studied in mice using the "whole-
body" autoradiographic technique. Diazepam accumulates rapidly in the 
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brain, kidney, liver and myocardium. High concentrations appear rapidly 
in the gastric mucosa and bile, and consequently in the stomach and 
intestine. 
The distribution patterns of diazepam and chlordiazepoxide were 
compared. Diazepam is distinguished by an extremely high uptake in the 
fatty parts of the body. The penetration of chlordiazepoxide in the brain 
is slower than that of diazepam. The distribution of both drugs and 
their related metabolites in the brain is quite similar. The white matter 
and the peripheral nerves retain radioactivity for a long period. 
Autoradiographic studies of 14C-diazepam in pregnant female mice 
demonstrated that there is a slow and rather slight penetration of the 
radioactive material through the placenta. Analysis of tissue-extracts 
obtained from mice treated with diazepam yielded at least seven metab­
olites originating from the labeled material. Rapid metabolic conversion 
of diazepam was observed. 
Half-life times of these products were determined. The metabolites 
showed a lower elimination-rate than diazepam. Nj-desmethyl-diazepam 
was found to be the major metabolite in mice. 
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CHAPTER VI 
KINETICS OF ELIMINATION OF ATARACTIC DRUGS 
OF THE MEPROBAMATE- AND DIAZEPINE-GROUP 
IN DOGS 
INTRODUCTION 
The great interest in the clinical use of ataractic drugs in the relief of 
anxiety and tensions of psychic and muscular origin promoted the 
development of large series of neuroleptic drugs of moderate activity : 
the socalled minor tranquillizers or ataractics. 
Meprobamate and homologues have proved their value, and more 
recently chlordiazepoxide and diazepam were introduced. These arc 
now the most common drugs in clinical and general practice. 
The previous reported analytical procedures on estimating propane­
diols and diazepines in biological medium made repeated analysis of 
these drugs desirable. The published pharmacokinetic data thusfar were 
often based on the sum of parent compound and metabolites. The rather 
rapid metabolism in laboratory animals, as well as in man, made a 
renewed analytical effort worthwhile. 
The purpose of these investigations was to study the fate of ataractics 
in dogs as an introduction to the study of these drugs in man. 
MATERIALS 
The following drugs, either cold or ,4C-labeled compounds, were investigated : me­
probamate, carisoprodol (N-isopropyl-meprobamate, Apcsan"), tybamate (N-n-butyl-
meprobamate, Solacen*), chlordiazepoxide ( L i b r i u m 4 ) and diazepam (ValiumK). Drugs 
of the meprobamate-group were I4C-labeled in the (unsubstituted) carbamate-group. 
The diazepines were 14C-labeled in the C2-position. 
To prepare dosages radioactive material was mixed with cold drug to the desired dose 
in such a way that 0.5-2 μC¡kg could be administered to the dogs (TABLE I). 
METHODS 
Liquid scintillation counting (LSC). 
Max. 1.00 ml of plasma was mixed with 1.00 ml of hydroxide of HyamineH (Packard) 
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or ι oo ml of 0 7 s M Soluene" (Packard) in a countvial The latter mixture had to be 
warmed for 30 minutes at ςο С When digestion was complete the liquid was mixed 
with 150 ml of scintillation cocktail of Brav (i960) 
1 00 ml of protein tree supernatant liquid after ultracentnfugation was mixed directly 
with 15 о ml of scintillation cocktail Counting was performed in a Nuclear Chicago, 
Mark I or a Packard 3380 ЛАА, liquid scintillation counter Corrections were made 
with the external standard method 
Specific activity of the injections was checked before administration by weighing about 
1 % of the dose and bv subsequent assav bv LSC 
Gas-liquid chromatography (GLC) 
Concentrations of meprobamate, cansoprodol and tv hamate m plasma and urine were 
determined according to the method of Dot 01 ^s et al (1967) 
Concentrations of diazepam in plasma were determined according to the method 
indicated by Dl· SUVA et al (1964), used by Мчіилссі et al (1968) and described in 
Chapter 7 
Determination 0/ free, plasma tiater, drug concentration 
Free drug concentration was determined b\ separating the unbound drug molecules 
from the drug-protein complex by centrifugation in a Christ Omega II 70 ultracentnfuge 
according to the method previously described (Chapter 2) 
1 о ml of protein free, supernatant Huid was assaved for radioactivity Radioactivity 
was correlated with mg of parent compound 1 
Determination of protein concenti at ion 
Total protein concentrations were determined with the biuret method Protein spectra 
were densitometncally assayed after electrophoretical separation on cellulose acetate 
using amido-black as dve (Clinical Laboratories ot Internal Medicine, St Radboud 
Hospital, Nijmegen) 
Animal experiments 
Dogs fasted for 24 h, were used in the experiments In a number of animals an im­
planted polythene catheter was introduced surgicalh into the aorta via the Л iliaca to 
allow repeated sampling from the unanaesthetized dog ( T I I O L N I N et al, i 9 6 0 In other 
experiments in dogs a poKthtnc catheter was introduced into the aorta via the A Icmorahs 
under local anaesthesia This catheter enabled sampling during the first day of the ex­
periment Intravenous injections were given into the V saphena 
Preparation of dosage 
Injection Drug was solubili^ed in 10 ",, ethanol-solution bv (2 "(,) polysorbate 80 
and injected as a 10 "„ suspension 
Oral dose Drug dissolved in dichlormethane was mixed with wheat flour and the 
solvent was evaporated T h e residue was mixed with minced meat and given orallv to 
the animal 
Urine 
Every 24-hours urine was sampled in a metabolism-cage Dailv, the volume and pH 
were measured and 20 о ml of the liquid was adjusted with alkali to pi I 7, filled up to 
25 о ml and brought in contact with 250 ml of a mixture of chloroform and carbon 
tetra chloride ( г ι ) (meprobamate-group) or diethy lether (dia/epine-group) The rocking-
extracting method of Ru-si· el al (1964) was used After at least 24 h of rocking s 00 ml 
8 
114 E. VAN DER KLEIJN 
of each layer was transferred to a countvial and the solvent was evaporated. The residue 
of the aqueous layer was made up to ι ml with water, mixed with 15.0 ml of Bray's 
scintillation cocktail and assayed for radioactivity. The residue of the organic layer was 
directly mixed with scintillation cocktail. 
RESULTS AND DISCUSSION 
Meprobamate-group. 
T h e concentrations of l 4 C-radioact ive drug were followed both in 
plasma and plasma-water of dogs at various periods after administrat ion 
of a single dose up to 24 h. After an initial rapid decline, following i.v. 
injection, the course of the concentration of the radioactive label showed a 
slight recovery after about 15 minutes. T h i s aspect was more pronounced 
in the plasma-water concentration of dogs treated with carisoprodol and 
tybamate. I n some experiments the parent compound was simultaneously 
measured. F r o m Fig. 1 it can be concluded that the metabolites show a 
m u c h slower elimination rate than the parent drug. 
Assay of total radioactivity appeared to be insufficient as an indicator 
because the drug is rapidly metabolized. Previous reported data of dogs 
give for meprobamate a half-life {t\) of 8 h ( H O F F M A N and L U D W I G , 1959), 
for carisoprodol t\ — 1 h ( D O U G L A S et al., 1962) and for tybamate t\ = 
4 h ( D O U G L A S et al., 1966). 
T h e "classical" spectrophotometric method of H O F F M A N and L U D W I G 
(1959) to determine meprobamate and homologues in biological m e d i u m 
is unable to differentiate between metabolites and parent c o m p o u n d . 
Considering the short biological half-lives of intact meprobamate, 
carisoprodol and tybamate compared to their pharmacologically inactive 
metabolites (BERGER and L U D W I G , 1964; BERGER et al., 1964) this method 
may give an inflated estimate of the pharmacodynamics . 
T h e described experiments can be based on a simple one c o m p a r t m e n t 
model and an exponential elimination (Chapter 1). 
T h e data of the drug and metabolites are summarized in T a b l e I. 
F r o m this table some conclusions can be made. T h e A'-substituted 
homologues show a shorter t\ than m e p r o b a m a t e itself. However, the 
rate of elimination of the radioactive material does not differ in a great 
extent. T h e distribution volumes of meprobamate (VA) and of the sum of 
drug and metabolites {V
s
) can be considered to be about similar. For 
carisoprodol and tybamate VA is about two times greater than Vs. T h e s e 
findings can be explained by the higher rate of metabolism and the higher 
affinity for the lipoid tissues of the body which appear to correspond 
with the higher lipophilic nature of the drugs. 
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FIG I 
Log concentration (C^J-time curves of parent meprobamate (\I) ( A A), 
carisoprodol (C) ( • • ) and tybamate (T) ( · · ) after i v administration 
of 25 mg kg to dogs * * give the course of the concentration of ''C-radioactivitj 
(C s) in plasma * * give the concentration of "C-radiodctivitv in plasma-« iter 
(CAf) The residues of the curves of Cs and C^ give the curve for the sum of the metab-
olites (CM) The insertions give the GLC patterns of the plasma extracts \ o metabolites 
can be detected by this analysis procedure Dealkylation of carisoprodol and t\hamate 
cannot be identified in plasma DBl· — dibutylphtalate (internal standard) 
TABLE I 
Drug 
Meprobamate 
Carisoprodol 
Tybamate 
Route of 
Adminis­
tration 
i.V. 
I.V. 
I.V. 
I.V. 
o. 
i.V. 
i.V. 
i.V. 
I.V. 
I.V. 
i.V. 
I.V. 
I.V. 
I.V. 
o. 
o. 
or 
m g 
I450 
1 0 0 0 
5 4 5 
5 0 0 
2 0 0 0 
8 0 0 
1043 
8 0 0 
6 5 0 
6 0 4 
5 6 8 
5 4 5 
6 6 0 
4 8 7 
•75° 
1800 
wD 
kg 
2 3 
2 0 
18 
2 3 
16.6 
3 2 
24-5 
2 2 
2 2 
2 4 
19 
2 0 
2 6 
2 1 
17.5 
1 8 
n/ 
mg/kg 
63 
5 0 
3 0 
2 2 
1 2 0 
2 5 
42.5 
36.4 
29-5 
25.2 
3 0 
27-3 
25-4 
23.1 
1 0 0 
1 0 0 
Radio 
active 
dose 
μα 
2 0 
IS ' 
2 5 
17 
1 0 
3 0 
13 
13-2 
26.4 
2 8 
8 . 4 
15-3 
9 . 0 
6 . 3 
l O . Q 
CV 
mg/l 
4 0 
2 8 
31-5 
3 3 
C.Ç» 
mg/l 
78 
64 
5 4 
5 5 
9 8 
5 0 
9 5 
7 4 
4 4 
5 5 
5 4 
4 5 
5 4 
3 9 
33-5 
ПА 
h ; min 
2 ; 40 
I 
: 43 
; 3 9 
í b 
h ; min 
Sí 42 
6 ; 17 
3 
2 ; 52 
6; os 
з;5° 
2 ; 2 б 
з ; 2 7 
2 
z ; o 8 
2 ; 04 
э;5° 
г; 4° 
> І О 
> IO 
л 
1 
2 0 
21.6 
і 8 
2 0 
Λ Α 
О' 
/0 
6 3 
9 0 
9 5 
7 7 
ι 
ν* 
I 
18.6 ] 
ΐ 5 · 4 
I O 
9-1 
2 0 
2 1 
8 . 4 
8 . 8 
13.7 
10.3 . 
I O . I 
9-9 
9 
4 5 
53-7 
Δ 3 
0/ /0 
9 3 
7 7 
5 5 
4° 
I 2 0 
8 5 
4 0 
4 0 
5 7 
5 4 
5° 
3 « 
4 3 
2 0 0 
Зоо 
Q^0 — dose; W D = weight of dog; D^ 0 = dose/kg body-weight; A = parent drug; S = sum of radioactivity of parent drug and metabolite(s); 
С = fictive initial concentration; V — fictive volume; Δ — 100. / д. 
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The distribution volumes of meprobamate, carisoprodol and tybamate 
calculated on basis of the plasma concentration do not differ significantly. 
It is, however, necessary to calculate these values on basis of the plasma-
water concentration. 
Because it has been shown that the protein-binding capacity of drugs 
of the meprobamate-group is concentration independent, it is allowed to 
calculate the distribution volume by multiplying with a factor 100 % / % 
unbound drug (Chapter 2). The V^-values for carisoprodol and tybamate 
should be corrected with a factor 100/57 = Ι ·8 and 100/35 = 2·9> 
respectively. 
In plasma extracts of meprobamate treated dogs no metabolites could 
be detected ( F I G . I , insertion). Ilydroxy-meprobamate is reported as the 
main metabolite in urine, but cannot be detected with the procedure used 
(LUDWIG et al, 1961). 
After carisoprodol treatment no metabolites could be distinguished in 
plasma. From experimental data obtained in mice, meprobamate was 
expected to be the majorm etabolite (VAN DER KLEIJN, 1969; Chapter 4). 
Dealkylation, however, could not be confirmed in dog plasma. It may be 
explained by the fact that the rate of metabolite (meprobamate) appear­
ance in the plasma is too slow compared to its rate of elimination by 
subsequent hydroxylation and excretion. Hydroxycarisoprodol was found 
-
ІУ 
M 
M 
k/Vj \ Л / — J 
Fio. 2 
G L C patterns of daily urine extracts of a dog after a single i.v. dose of tybamate. In 
the pooled urine of the first two days parent drug and meprobamate as metabolite can 
be identified in small amounts. The other peaks are due to the drug additive PEG 300. 
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to be the major metabolite in urine of dogs by EDELSON et al. (1965) and 
DOUGLAS et al. (1966). 
In the plasma GLC-spec t ra of the tybamate experiments no metabo-
lites could be detected. In urine, in addition to small amounts of parent 
drug, meprobamate could be detected following the first two days of the 
experiment ( F I G . 2). Hydroxylation is suggested to be the fastest step in 
the biotransformation of carisoprodol and tybamatc in dogs. 80-95 % 0 ^ 
the radioactive material due to meprobamate or homologues could be 
recovered in the urine after 2-3 days following administrat ion. T h e 
major portion of the drug is excreted as highly hydrophilic compounds 
( F I G . 6). 
T h e simple representation of the data in Table I is only allowed when 
the initial concentration decline during the first distribution period is 
neglected. When enough data are determined following rapid injection 
of the drug an interpretation according to a two compar tment open sys-
tem could have been possible (Chapter 1). 
Diazepine-group. 
T h e most specific, non-isotope method to determine chlordiazepoxide 
in biological medium has been reported by K O E C H L I N and D 'ARCONTE 
(1963), but here too, inherent to the procedure the demethylated and de-
aminatcd metabolites are simultaneously measured. Gaschromatographic 
separation of intact chlordiazepoxide has not yet been successful. 
Hydrolysis to aminochlorbenzophenon has more disadvantages than 
the spectrophotofluorometric method since most metabolic transforma-
tions take place in the 7-membcred ring that is split off dur ing hydrolysis 
(SCHWARTZ et al., 1968). Th i s last a rgument holds equally well for 
diazepam. T h e rapid appearance in laboratory animals of metabolites 
with the same analytically detectable moiety, made renewed estimations 
of these drugs likely, moreover since biotransformation may lead to 
decrease of pharmacological activity (RANDALL et al., 1965; G A R A T T I N I , 
1968). 
In the case of chlordiazepoxide, biotransformation can theoretically 
lead to structures of increased pharmacological activity and increased 
lipophilic nature. It is doubtful, however, that the rather slow rates of 
metabolism will have significant influence upon the latentiation kinetics 
of this drug (SCHWARTZ et ah, 1968). 
T h e concentration of 14C-radioactive drug was followed in plasma and 
plasma-water for 160 h after intravenous and oral administration. 
T h e more complex course of the concentrations of radioactivity in 
plasma due to the diazepines made analysis of the data into simple first 
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chlordiazepoxide(Tng/l plasma) 
001 
-[ I) and of diazepam 
FIG. 3 
Log concentration-time curves of chlordiazepoxide ( ~— 
( " < ) after i.v. injections of 3 7 , mgikg and 1 mg'kg, respectively. The course 
of parent diazepam is much steeper than that of the total radioactivity. The rapid secondarv 
recovery of the plasma and plasma-water 14C-conccntration after diazepam injection 
indicates the rapid metabolism leading to the formation of compounds with smaller 
fictive distribution volumes and lower binding capacity The elimination of chlordiaze-
poxide appears to be much slower and the slighter secondary rise of the curves suggests 
slow biotransformation. 
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order one or two compartment kinetics impossible. Of chlordiazepoxide 
in dogs ti = 7 h was reported (RANDALL, i960; KOECHLIN et al., 1965) 
and of diazepam tl = 9-16 h (SCHWARTZ et al., 1965). 
The drug concentration decline was followed by means of their radio-
active label situated in the Ca-position. In addition to the parent drug, 
metabolites were included in the measurements. In some cases diazepam 
could simultaneously be measured by GLC. 
From Fig. 3 it appears that the elimination of chlordiazepoxide is slower 
than of diazepam. It can be demonstrated that intact diazepam is more 
rapidly eliminated than its related metabolites. 
It may be noted, that after the initial concentration decline a pronoun-
ced recovery of the 14C-concentration of diazepam can be observed which 
is almost absent in the case of chlordiazepoxide. This phenomenon is 
more pronounced to the plasma-water concentration especially when 
higher doses are administered (FIG. 3 and 5). After oral administration of 
chlordiazepoxide biological half-lives of the label are rather equal while 
large individual variations are observed after intravenous administration 
(FIG. 4). The concentration of radioactivity reaches its maximum between 
2-4 h after administration, and the rising portion of the curve is erratic. 
Of chlordiazepoxide some data are given in Table II. 
Individual differences arc pronounced also after oral administration of 
diazepam while the elimination pattern of radioactivity shows more 
mutual similarities after i.v. administration (FIG. 5). 
In the course of the concentration of radioactivity due to diazepam at 
least three phases can be distinguished. When the rapid initial decline is 
neglected the curve can be treated as a bi-exponential curve, and data on 
basis of a two compartment system are summarized in Table III (compare 
Chapter 1). There are, however, insufficient data for exact analyses of the 
parameters. From whole body autoradiographic distribution studies 
evidence is obtained that the drug is rapidly and extensively exchanged 
with the lipoid tissues of the body. The clearance ratio kl2jk2l in a two 
compartment system will be very great. Since this ratio is unknown, it is 
not possible to predict the concentration course in the peripheral com-
partment nor the fictive distribution volume. No simple relations are 
observed between various doses and plasma concentration (F IG. 4 and 5). 
In the plasma spectra of diazepam treated dogs desmethyldiazepam 
appears after approximately 1 h after injection in the region of the dia-
zepam peak. Oxydiazepam and oxazepam can hardly be detected in the 
spectra. 
About half of the dose is excreted with the urine (FIG. 6). The rest is 
excreted via the feces (SCHWARTZ et ah, 1965). 
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Theoretical model for interpretation of the secondary recovery of the 
log , 4 C plasma concentration-time curve after intravenous injection. 
The use of a radioactive isotope as tracer for a drug in the body may 
give difficulties when the label passes through all metabolic pathways. 
ct-brJiazepoxidc (mg/i plasma) 
FIG. 4 
Log. concentration-time curves of 14C-chlordiazepoxide (U- - Í ') following i.v. 
and oral administration of i) 3.75, 2) 2.2, 3) I . I , 4) 10, 5) 8.3 and 6) 5 mg/kg respectively. 
T A B L E II Ν 
R o u t e of 
D r u g a d m i n i - Q / \\'D Ό/ U C h2s il 
s trat ion 
m g kg mg, kg μΟί mg/1 
C h l o r d i a z e p o x i d c i.v. oo 24 3.75 22.-). 3.8 50 
< 
i.v. 50.6 23 2.2 21.8 2 26.5 ^ 
i.v. 22.3 20 1.11 10.4 1.05 . 1 0 0 
oral 210 21 10 34.9 25 16 
oral 166 20 8.3 20.8 20 16.; 
oral 114 23 5 23.3 5.6 16 
1 
L 2 — i n t e r c e p t of second p h a s e of log c o n c e n t r a t i o n - t i m e c u r v e ; i ^ = half-life of flat p o r t i o n of the bi-exponentia l curve. 
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The appearance of metabolites into the plasma after intravenous ad­
ministration can be interpreted by the equation which is used to describe 
absorption of drugs versus elimination (DOST, 1968; Chapter 1, equation 
14). 
':i ΤΠΙ'ΡΪΓΓ. ,rng/. y\ ir nia,-
F I G . 5 
Log. concentration-time curves of "C-diazepam (c '" ) following i.v. and oral 
administration of i) 6.7, 2) 4.2, 3) 1.4, 4) 3, 5) 2.1, 6) I, 7) 0.88 and 8) 0.36 mg/kg. 
Diazepam 
TABLE III .£ 
Route of , . 
Drug admini- Q / ' WD ι D^» j L, L 2 V! ДА í j , ti, 
stration ' 
mg kg mg/kg mg/l mg/l 1 % h ; min h ; min 
oral 
58-4 
26.5 
22 
7 
1 2 0 
8 0 
3 2 
5^ 
, 23-5 
2 7 
2 5 
IQ 
• 18 
19 
, 23 
ι ? 
2.θ6 
O.98 
Ο.88 
О.36 
6.7 
4-2 
ΐ · 4 
1
 3 
3-5 
2.0 
"·°5 
Ο.Ι7 
1 '•б 
0 . 4 
O.I3 
ι 0.04 
2 . 8 
0 . 9 
0.45 
0.40 
11.45 
11.04 
18.06 
33-3 
5 0 
4 1 
7 2 
175 
ι ;5° 
2 ; 10 
2 : 4 0 
2 : 5 0 
1 6 
16; 10 
15; 15 
2 5 
1 9 
1 8 
9 
и 
< 
> 
•2, 
С 
m 
JO 
Ξ 
2 
I 
L«! = intercept of residue of biphasic curve with ordinate; L2 = intercept of second phase of log concentration-time curve; tix — half life 
of residual curve; t\t — half-life of flat portion of the bi-exponential curve. 
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car i soprodol 
total С ur ine 
chloroform phase 
d i a z e p a m 
atiucous p h a s e 
4 
d a y s d a y s 
F I G . 6 
Cumulative urinary excretion patterns of carisoprodol and diazepam. About 81 % 
of the administered carisoprodol can be recovered from the urine. The major portion 
is excreted as water-soluble material. Of diazepam about 57 % of the dose can be found 
in the urine. The major portion of the radioactive material can be extracted with ether. 
It is suggested that the conjugates of the main metabolite in urine : oxazepam, (RUEI.IUS 
et al., 1965) are rather unstable. 
This equation reads for drug and metabolite together : 
С ,
(
 = {QA*IVA) • e-^ + W,VM) • [гш!(т2М - τ)] · [kMJ(kM3 + kla)] 
•(e- 2M 
Ί 
where : τ = the time constant for elimination of drug A, which is con­
sidered to be equal to the time constant of metabolite appearance in the 
plasma, тгм = the time constant of elimination of the metabolite, and 
Cs' = molar concentration of radioactive material. 
In the group of ataractic drugs elimination is predominantly controlled 
by biotransformation. Since the lipophilic nature of the compounds 
prevents their renal excretion, k13 can be neglected. The factor kM3¡ 
(kM3 + ^3) may thus be considered to be equal to ι. Т2
М
 can be derived 
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from the last phase of the plasma curve of the radioactive label when the 
parent drug is considered to be eliminated. When the distribution volu­
mes of parent compound and metabolite are known then the time 
constant of the parent compound can be determined. Fig. 7 shows two 
examples where the distribution volume of the metabolite (VM) is varied. 
M cone 1 
F I G . 7 
Theoretical log. concentration-time curves calculated for two different fictive distri­
bution volumes of the metabolites. Cj = plasma concentration of sum of metabolites (M) 
and drug (A) together; CSF = plasma-water concentration of drug and metabolite 
together; С
л
 — concentration of parent drug in plasma; CAF — concentration of parent 
drug in plasma-water, protein-binding capacity drug : 50 0 0 , protein-binding capacity 
metabolite : о " „ ; С / — 3 y ю - " Μ; т
А
 •= т 1 М — 1.44 h; т 2 М — 5-76 h. 
Biotransformation of meprobamate, carisoprodol, tybamate and 
diazepam leads to compounds of reduced lipophilic nature expressed as 
partition coefficients and reduced protein-binding capacity. The progres­
sively decreasing protein-binding capacity of the 14C-label during the 
course of the experiment accentuates the steeper rise in the CSF -curve 
( F I G . 1, 3 and 5). 
These models allow at least the qualitative interpretation of experi­
ments when drug concentrations are followed by an unsclective analysis 
procedure. 
The following conclusions can be made for the dogs : 
1. Drugs of the meprobamatc-group are rapidly metabolized and the 
parent drugs show higher elimination rates than their related metabolites. 
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2. Carisoprodol and tybamate are predominantly metabolized to 
hydroxy-carisoprodol and hydroxy-tybamate respectively, and excreted 
as such or as conjugates with glucuronic acid (DOUGLAS et al., 1962, 1966). 
Faster elimination corresponds to higher lipophilic nature. 
3. After tybamate treatment a small amount of parent drug is excreted 
and meprobamate can be recovered in urine (FIG. 2), (DOUGLAS et al., 
1966). 
4. The concentration time curve of l4C-chIordiazepoxide after intra-
venous administration differs markedly in various dogs. After oral 
administration, a closer resemblance in elimination rate is observed. 
However, fluctuations in reaching the maximum plasma concentration, 
that is reached between 2-4 h after administration, suggest retarded 
absorption of the drug from the gastro-intestinal tract or abundant enter-
al recirculation of the drug and/or the metabolites. 
No simple relations between dose and maximum plasma concentration 
are observed. 
5. Diazepam and its related metabolites show the same individual 
variations as chlordiazepoxide. After i.v. administration some mutual 
resemblances in the concentration course of 1'1C-diazepam is observed. 
The metabolites show much slower elimination than the parent com-
pound. Biotransformation is reported to yield compounds of decreased 
activity and of lower lipophilic nature. 
No simple relations between dose and plasma concentrations were 
found. The multiphasic elimination curves require more data and study 
to be interpreted in terms of two or multi-compartment pharmacokinetics. 
SUMMARY 
Plasma concentrations of meprobamate, carisoprodol, tybamate, 
chlordiazepoxide and diazepam were studied in dogs after i.v. and oral 
administration. The 14C-labeled compounds were determined by liquid 
scintillation counting giving the sum of drug and metabolites. In some 
cases the parent drug was simultaneously assayed gaschromatographical-
ly. Metabolites appeared to have longer biological half-lives than the 
parent compound. The concentration course in plasma of drugs of the 
meprobamate-group is interpreted in simple one-compartment kinetics. 
Chlordiazepoxide- and diazepam-treated dogs showed considerable 
individual variations. No simple relation between dose and plasma con-
centrations could be established. The multiphasic log concentration-time 
curves of diazepam require further study. 
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CHAPTRR VII 
PHARMACOKINETICS OF DIAZEPAM IN MAN 
INTRODUCTION 
Diazepam (Valium11 ) is a frequently used ataractic in the clinical and 
general practice of light neuroses and psychic and muscular tensions. 
Since, unfortunately, only subjective criteria in the benefit of the therapy 
can be made, a more objective approach is desired on the basis of 
plasma concentrations. 
Diazepam levels have been studied in man and laboratory animals. 
Dealkylation, hydroxylation and subsequent conjugation were reported 
as the major metabolic pathways. Desmethyldiazepam appeared to be the 
major metabolite in plasma. Free and conjugated oxazepam was pre-
dominantly found in urine (RUELIUS et al., 1965; SCHWARTZ et al., 1965; 
DE SILVA et al., 1966). Following a single orai dose of 3H-diazepam a 
multiphasic concentration decline was reported by SCHWARTZ et al. (1965) 
with an overall half-life of about 3 days after a faster initial phase. From 
the work of DE SILVA et al. (1966) it appeared that diazepam shows a 
half-life of 30 h after an initial faster period following a single oral dose of 
of io mg diazepam, but of 2-3 days after repeated doses. The t\ of des-
methyldiazepam appeared to be much longer. The elimination of dia-
zepam thus seemed to be greatly dependent on the preceding dosage 
history. Incomplete distribution after a single dose over all possible 
compartments was used to explain the erratic concentration-time course 
of the drug. 
RIEDER and RENTSCH (1968) reported that desmethyldiazepam and 
diazepam were the major metabolites of medazepam (C2-dcsoxydiaze-
pam) in man. From their data it may also be concluded that desmethyl-
diazepam is much slower eliminated than diazepam. From experiments 
in mice and dogs longer half-lives of the main metabolites other than 
that of the parent compound were found (VAN DER KLEIJN, 1969). 
Since biotransformation affects the pharmacological activity only 
quantitatively (RANDALL et al., 1965; GARATTINI, 1968), differences in 
biological half-life may have consequences during chronic treatment. 
9 
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It is more reasonable to derive pharmacokinetic parameters from con­
centration levels after chronic treatment, when accumulation has led to a 
plateau level and a steady state is established. The purpose of this in­
vestigation was to study pharmacokinetics of elimination and metabolism 
of diazepam in man on the basis of : 
a. plasma concentration decay curves of drug and metabolites after a 
single oral dose of 30 mg of diazepam, b. plasma levels during chronic 
therapy with oral doses of io mg, 3 times daily, and с plasma concen­
tration decay curves of drug and metabolites after completion of the 
therapy. 
MATERIALS 
Instrument. 
The F & M model 402 dual column gaschromatograph (GLC) equipped with a e j Xi-
elcctron capture detector (ECD) and a flame-ionization detector (FID) combined with 
a 1 MV Moscley recorder was employed. 
Columns : 3 meter glass and copper tubes (internal diameter 2.8 mm) packed with 
3.8 "o UC-W 98 methyl silicone on 80 100 mesh Diatoport S (Packing . Hewlett-
Packard, Amsterdam); carrier: nitrogen; purge: argon-methane (90: 10). 
Instrument settings. 
Temperature: column: ζζο" С; injection por t : 330o С; detector block: 290" С ; 
auxiliary heating : 300° C. 
Gas-flow ra te : ECD : N^ 75 ml/min; argon-methane 200-220 ml/min, measured at 
detector outlet. 
FID : Nj 2.2 — 50 ml/mm; H 2 3.0 — 40 ml/min; 0 2 4.5 — 500 ml/min. 
Pulse interval : 50-150 μβεΰ; amplification : range 1-10; attenuation 2-16; chart speed : 
0.25-0.5 inch/min. 
METHODS 
GLC procedure. 
2 00 ml of a heparimzed plasma sample containing diazepam and derivatives is trans­
ferred into a 40 ml glass-stoppered centrifuge tube; 2.0 ml 0.2 M phosphate buffer 
solution (pi I — 6.8) and 10 ml diethyl ether (reagent grade) are added. The stopper 
is sealed with one drop of water. The tubes are thoroughly shaken for 10 mm. The 
layers are separated by centnfugation. The organic layer is transferred into another 
40 ml glass-stoppered tube. The sample is re-extracted with ether. The combined ether 
phases are evaporated in a watcrbath at 30е С by an air current. The residue is rinsed 
with dried ether to the bottom of the tube and re-evaporated. The residue is dried in 
a vacuum dissiccator over anhydrous CaCl¿. 
too μ.\ of и-hcxane containing 5 fig 2-N-bcnzyl-amino-5-chlor-benzophenonc (BACB) 
is added. The residue is dissolved for io m m ; 1-4 μ\ of the liquid is analyzed. Concen­
trations are correlated with the ratios of the peak areas of compound and internal standard 
calculated from peak height, and width at half height. 
G L C injections containing a 2 ng compound corresponding to a 25 ng/ml sample can 
accurately be determined. Samples containing 10 ng'ml sample can qualitatively be 
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identified. Linearity is determined for 50-1000 ng diazepam/ml sample and 50-1000 ng 
desmethyldiazcpam/ml sample ( F i e . 1). 
T h e retention times of oxazepam, diazepam, desmethyldiazepam and B A C B account 
for about 6, 8, 9.5 and 17 m m respectively. 
Determination of protein. 
Total protein content was determined by the biuret method. Protein spectra were 
densitometncally measured after electrophoretical separation using amido-black as dye 
(Clinical Laboratories of Internal Medicine, St. Radboud Hospital, Nijmegen). 
Determination of protein binding. 
Separation of free drug and drug-protein complex was achieved by the ultracentrifuge 
method as previously described (VAN DER K L E I J N , 1969; Chapter 2). 
peak area DRUG 
peak a r e a BJ^CE 
2 5 
я deanf hy'diaiepam 
/ 
/A 
Fic . 1 
Calibration curves of diazepam ( · -
-·) 
F I G . 2 
Relationships between amount and re-
and desmethyldiazepam (ψ у ) in sponse for desmethyldiazepam ( V , TX 
human plasma. Pulse interval 150/¿sec. diazepam (O, · ) and oxazepam ( Д , A) at 
pulse intervals of 150 fisec ( ) and 
50 jitsec ( ). 
RESULTS AND DISCUSSION 
Method. 
The mean therapeutic plasma concentration levels of diazepam were 
found to range from 0.4-2 μg¡m\. For the determination of these low 
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concentrations in the presence of metabolites and biogcnous compounds 
a sensitive and specific method is necessary. 
A method proposed by DE SILVA et al. (1964) enabled the determination 
of diazepam levels in plasma after hydrolysis in acid medium in the 
nanogram range. Determination of the intact drug on a 2 feet 5 % 
silicone DC 11 column with ECD was advised against because of its 
slight separation capacity. Although the hydrolysis method is recommen-
ded for the simultaneous determination of diazepam and its metabolites 
in the same sample, the extraction and re-extraction procedure is insuf-
ficient for quantitative extraction of oxazepam and oxydiazepam. Des-
methyldiazepam was found to be the major metabolite in plasma. The 
procedure is thus useful to plasma where no other metabolites were 
identified by the authors. 
% b o u n d 
100 -, 
% free 
9 0 
b inding DIAZEPAM-HUMAN PLASMA 
32 o C;5h ;70 0 0 0 r P m 
10 
10 12 14 16 
>ig/ml 
FIG. 3 
Protein-binding capacity of diazepam in human plasma measured according to the 
ultracentrifuge method. 
AIARCUCCI et al. (1968) returned to the analysis of intact drug by GLC 
on a Silicone gum column of 2 m length which allowed the clean separa-
tion of oxazepam, diazepam, desmethyldiazepam and oxydiazepam 
successively. BACB was used as an internal standard. 
In the experiments reported here a 3 m column was used and the flow 
rate of the carrier gas was increased to improve the dissolving power of 
the column. Electron capture detection was preferred over FID for 
performance of cleaner separation and about a 50-fold increase in sen-
sitivity. eaAV-ECD appeared to be the most sensitive for N-desmethyl-
diazepam. Diazepam could be detected with sensitivity reduced to 1/3 and 
oxazepam to 1/2. Linearity of response was achie\red over the expected 
concentration range in the plasma (FIG. 2). The method described is 
simple and rapid. Diazepam and its related metabolites (F IG. 5), nitra-
zepam and medazepam, can separately be assayed (nitrazepam only by 
FID). 
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In all experiments oxazepam and oxydiazepam could not be identified 
in plasma extracts ( F K ; . 6). Free and conjugated oxazepam are reported 
as the major metabolites in urine (RUELIUS et al., 1965; SCHWARTZ et al., 
mg/] ρ a s r r a 
О 4 8 12 16 20 24 4 8 12 le 20 24 К 
1 Ζ 3 4 5 6 7 в 9 10 II 12 :3 И /5 '6 
ш mmtmmtttittmtmmmmmtt 
F I G . 4 
Log concentration-time curves of diazepam and its major metabolite N-desmethyl-
diazepam after an initial dose of 30 mg followed b> chronic treatment of 3 daily doses 
of io mg diazepam orally in 5 patients. 
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1965). It may be concluded that elimination by renal excretion is a faster 
process than hydroxylation and subsequent conjugation. 
J j 
REFERENCE MIXTURE REFERENCE PLASMA EXTRACT 
atflO 0 25i/min 
О D DD BACB О D DD BACB 
UjlK-AyJ \ 
12 16 20 24 12 16 20 
mm 
F I G . S 
G L C patterns. 
A. Separation of oxazepam (O), diazepam (D), dcsmcthyldiazepam (DD) and 2N-
benzyl-amino-5-chlor-benzophenone (BACB) in hexane. 
B. Separation of O, D, D D and BACB after extraction from plasma. 
Concentration-time course of diazepam in human plasma. 
From experiments in dogs it appeared that interpretations of diazepam 
curves in simple two-compartment kinetics are not possible (Chapter 6). 
Analysis of plasma extracts of diazepam-treated patients after a single 
dose seems to show great individual variations in maximum concen­
tration, in time necessary to reach the maximum, and in metabolite 
appearance rate. 
In the first concentration decay period fluctuating values are observed. 
The t\ showed variations between 10 and 40 h ( F I G . 4). The rather long 
half-life of diazepam gave rise to accumulation. After about 4 days the 
accumulation plateau is reached. The t\ and the accumulation plateau 
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concentration (CApi) allows the calculation of the fictive distribution 
volume of diazepam at the steady state of the drug concentration in all 
possible compartments. 
According to VAN ROSSUM and TOMEY (1968) : 
^Чі -
і-щслч мпт 
When CApi is determined, the dosage interval Δ t is known, i | is 
known, then the fictive distribution volume can be calculated, under the 
assumption that absorption from the gastro-intestinal tract is complete. 
The values for V/ are given in Table I. 
D DD БАСВ 
F I G . 6 
G L C patterns of plasma extracts. 
A. Blank; B. 5 h after the first dose; C. 7¿ h after the last dose following chronic 
treatment during 14 days. 
Since only the free concentration is involved in the exchange of drugs 
with other tissues, the fictive volume has to be calculated from the plas-
ma-water concentration (KRÜGER-THIEMER, 1968). 
Estimation of protein binding in outdated plasma shows no con-
centration dependence over the therapeutically possible concentration 
range (FIG. 3). So the correct value for
 ( can simply be found by multi-
plication with i/fraction unbound drug (1/0.04 — 25)· 
Fig. 4 shows the concentration-time course of diazepam and des-
TABLE I 
1 2 2 1 2 2 I 2 
Pa t i en t S y m b o l Sex Age Body CA¡,i С, „і ι taCA ' tat\f 
. Weight , tlA tlA ti¡M \ , л \ ! A V , M \,AtTn V M l r r c 
years kg mg/1 mg, 1 h h h 1 1 1 1 1 days days 
Ν Δ <ί 5 i 6o 1.7 о.8 — — > 50 · — — . . - н о —
 1 — 4 
К О ¡J г о 6з 1.4 0 · 6 > 3 0 8.7 > 5 o > 4 0 n · 2 > i 5 o > 1000 280 4 
M i 35 70 1.0 0.8 — 12.3 15 — ; 22.1 > 34 — 520 4 
D i · î S3 5 8 ^ 0 0 · 5 2 I - 5 — > S O 39 — > i 8 o ' 1000 , —
 ¡ 4 
D j Ш (J 45 64 0.5 0.28 12.3 23 > 5 θ 44.3 85.5 > 3 2 θ 1100 2100 — 
Cpt - average p lateau concentra t ion. A — p a r e n t d r u g (d iazepam), M - m e t a b o l i t e ( d e s m e t h y l d i a z e p a m ) . 1 — first per iod after single dose 
of 30 m g d i a z e p a m . 2 = per iod after last dose of i o m g d iazepam. \ ¡ — fictive vo lume calculated from plasma concent ra t ion . дгге — fictive 
vo lume calculated from plasma-water c o n c e n t r a t i o n . t
a
, — t i m e of reaching p lateau level. 
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methyldiazcpam in five patients. It may be noted that it is difficult to 
derive exact pharmacokinetic parameters from the observed data. The 
biological half-life and hence τ cannot be determined exactly. On the 
basis of highly approximated ti values (TABLE I) the fictive distribution 
volume is calculated. It appears that Vf values show capricious variations. 
From t,,,., the time in which the plateau level is reached it can be cal­
culated that i j of diazepam is approximately 1 day and tl of dcsmethyl-
diazepam is about 30 h (tl = t}¿tH. = 1/4 t(ll). tac of diazepam shows much 
resemblance in 4 patients. 
It may be clear that diazepam shows a great fictive distribution volume 
(V/) which will very slowly be cleared. The elimination occurs predomi-
nantly by biotransformation since no intact diazepam could be recovered 
from urine. Although diazepam and desmethyldiazepam show long 
biological half-lives the accumulation level becomes not very high. The 
rapid exchange with other compartments and the great fictive distribution 
volume make interpretations of plasma concentration levels soon doubt-
ful. Because of the high clearance ratio к
т
!к
т
 plasma concentrations will 
never synchronically follow the fluctuations of drug concentrations in for 
distribution and action specific regions containing high amounts of drug 
(Chapter 1). Therefore it is not excluded that rather small variations in 
plasma concentration will have great consequences in a peripheral 
compartment. 
The high uptake of diazepam in adipose tissue (VAN DER KI.EIJN, 1969) 
may also give rise to individually varying extension of the fictive 
distribution volume. The fictive distribution volume is generally con­
sidered to be constant for one individual and drug, independent of the 
applied dose (DOST, 1968). 
It is questionable if this constant value will be reached for diazepam 
and other lipophilic drugs with high specific regional distribution at 
low dosages. The great capacity of this volume may explain the great 
inter- and intra-individual variations. 
The weakly basic nature of diazepam (pK,, = 3.3) and its high lipid 
solubility can be used to explain the abundant gastroenteric circulation 
and its strong binding capacity to macromolecules. These factors can 
contribute to a sustained rcabsorption of the drug. Therefore, composi­
tion of diet, condition of gastrointestinal tract etc. will be important 
factors in the absorption of the drug. In addition to the lipophilic parts of 
the body, the gastrointestinal tract may function as a drug depot, thus 
increasing the fictive distribution volume. 
After a single dose the action of diazepam is based on the presence of 
parent drug. However, after chronic treatment the action must be con-
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sidered to be due to diazepam and desmethyldiazepam together. The 
diazepam levels no longer reflect the therapeutic concentration. Although 
desmethyldiazepam is reported to show decreased and slightly modified 
activity in laboratory animals (RANDALL et al., 1965; GARATTINI, 1968), 
the contribution to the therapeutic effect of this accumulating metabolite 
cannot be neglected. 
Further investigations over longer medication periods in man are 
necessary to clarify the intricate pharmacokinetics of this extensively used 
drug. 
Casuistical observations. 
a. In one patient (//) only very small amounts of desmethyldiazepam 
could be detected in plasma during the first three days of medication. Due 
to undesired clinical reaction to the therapy intake of diazepam was stop­
ped. 
b. An ambulant patient was examined for suspected overdosage of 
diazepam. From the plasma GLC pattern it was possible to conclude that 
the concentration of diazepam was not higher than the normal thera­
peutic level. 
From the amount of desmethyldiazepam, besides diazepam, it could be 
concluded that the drug had been taken for at least one week. 
The simultaneous measurement of diazepam and desmethyldiazepam 
in ambulant patients allows the identification of either occasional or 
chronic intake or acute abuse. 
с Recently an alcohol addicted patient (B) was treated with diazepam. 
Considerably shorter biological half-lives could be found than in the 
previously described patients. Traces of desmethyldiazepam could only be 
detected after two days following the initial dose of 45 mg diazepam. 
The dosage schedule was 3 d. d. of 15 mg. 
SUMMARY 
Pharmacokinetics of diazepam (Valium") and its major metabolite 
were studied in plasma from psychiatric patients on fixed dosage re­
gimens. For this purpose GLC with e 3M-electron capture detection of 
the intact compounds was used. 
As a consequence of the regimens an accumulation plateau level of the 
drug and its primary metabolite, Nj-desmethyldiazepam, was achieved, 
which enabled the calculation of the fictive distribution volume (Vf) of 
the drug and its biological half-life (t%). Large individual variations were 
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demonstrated. Plateau levels of diazepam and desmethyldiazepam were 
reached after about 4-5 days indicating almost equal biological half-lives. 
Distr ibut ion over a large fictive volume, negligible excretion, predomi­
nant elimination by biotransformation and storage in depots in adipose 
tissue and gastrointestinal tract are assumed to be responsible for t h e 
long half-life and the individual variations. 
A method is described for the quantitative determination of diazepam 
and its major metabolites in biological m e d i u m in the therapeutic 
concentrat ion range. T h e method is also valuable for medazepam 
( N o b r i u m 1 1 ) . Ni t razepam (Mogadon 1 1 ) can be determined by using a 
flame-ionization detector. Plasma G L C patterns enable the identifica­
tion of occasional or chronic intake or acute abuse. 
T h e clinical studies on diazepam were conducted by : Dr. G. P. J. A. VAN LIER, 
Psychiatrisch Centrum " S t . Servatius", Venray, Dr. G. C. D F RUYTER DL W I L D T , Psy­
chiatrisch Ziekenhuis "Brinkgreven", Deventer, and Dr. J. VAST D m L I N D F N , Psychia­
trisch-Neurologische Kliniek, " S t Radboud" Ziekenhuis, Nijmegen. 
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PHARMACOKINETICS OF ATARACTIC DRUGS 
FARMACOKINETIEK VAN ATARACTICA 
SAMENVATTING 
(SUMMARY IN D U T C H ) 
Het overvloedige en nog steeds toenemende gebruik van kalmerende 
middelen in de klinische en algemene praktijk is de aanleiding geweest 
tot het verzamelen van gegevens betreffende de farmacokinetische, 
analytisch chemische en klinisch farmaceutische aspecten van enkele 
geneesmiddelen welke veelvuldig toegepast worden bij neuroses, 
angsten, agressiviteit en spanningen. Tevens worden deze middelen om 
hun specifieke centrale spierrelaxerende en anticonvulsieve eigenschap-
pen toegepast in de kliniek. 
Vaak is de keuze van het juiste psychosedativum, meer dan bij welke 
andere groep van geneesmiddelen, afhankelijk van subjectieve over-
wegingen zowel van de behandelende arts als van de patiënt. 
Naast de reeds gedurende meer dan een halve eeuw gebruikte bar-
bituraten, bromiden, zuurureïden en chloral-derivaten is omstreeks 1950 
met de introductie van meprobamaat een ontwikkeling ingezet van 
geneesmiddelen, die ter onderscheiding als psychosedativa gekenschetst 
worden. Deze middelen onderscheiden zich van de „klassieke" sedativa 
doordat zij een kalmerende werking vertonen bij doses die nog geen 
sufheid of slaperigheid veroorzaken. De specifieke werking bij angst- en 
conflictsituaties, die ook bij proefdieren aantoonbaar is, maakt dat deze 
middelen als ataractica een eigen groep vormen. In de Amerikaanse 
literatuur worden deze verbindingen als minor tranquillizers aangeduid, 
welke onderscheiden kunnen worden van de major tranquillizers, waar-
van de fenothiazines (chloorpromazinc) en de butyrofenonen (halope-
ridol) de voornaamste vertegenwoordigers zijn. Deze als neuroleptica 
aangeduide geneesmiddelen worden voornamelijk bij de behandeling van 
psychoses gebruikt. 
Het doel van het onderzoek was de bestudering van de distributie, 
biotransformatie en eliminatie van de geneesmiddelen van de meproba-
maat- en de diazepine-groep. 
Ataractica vertonen in het algemeen een grote affiniteit voor de vet-
achtige weefsels van het lichaam, waardoor slechts geringe concentraties 
in de voor chemische analyse toegankelijke lichaamsvloeistoffen aan-
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wezig zijn. De dikwijls moeilijk analyseerbare verbindingen en de door de 
biotransformatie gelijktijdig optredende chemisch nauw verwante, doch 
farmacologisch van elkaar verschillende metabolieten hebben bij eerder 
onderzoek niet altijd de juiste gegevens opgeleverd. 
Het veelal langdurig gebruik van deze ataractica maakt het wenselijk 
inzicht te hebben in de biologische verblijftijd welke gekarakteriseerd 
wordt door half-waardetijden (tl) of tijdskonstantes (τ), door klarings-
konstantes (k) en door het verdelingsvolume (vanwege het principieel 
ontbreken van gelijkenis met de fysiologische verdelingsruimten aange­
duid als fictief verdelingsvolume, V/). 
In hoofdstuk 1 wordt een algemeen overzicht gegeven van de factoren, 
die een rol spelen bij de resorptie, distributie, eliminatie en biotransfor­
matie van geneesmiddelen. 
In hoofdstuk 2 is de nadruk gelegd op enkele facetten, die invloed 
kunnen hebben op de kinetische processen in het lichaam, zoals eiwit­
binding en fysisch-chemische eigenschappen. De uitwisseling met andere 
weefsels wordt mede bepaald door de concentratie in het plasmawater. 
Het is belangrijk de omvang en de aard van de eiwitbinding te kennen. 
In hoofdstuk 3 is een beschrijving gegeven van de techniek van de 
macroautoradiografie. Deze techniek maakt het mogelijk de verdeling van 
water- en vet-oplosbare verbindingen zonder gevaar voor verstoring van 
het biologisch milieu in intacte proefdieren te vervolgen. Een geringe 
variatie maakt deze techniek geschikt voor het bestuderen van de ver­
deling van vluchtige verbindingen en/of van vluchtige radioactieve 
afbraakproducten. Dank zij deze methode kunnen geneesmiddelen ook 
in voor de analyse ontoegankelijke weefsels en organen ge\Olgd worden. 
Combinatie met de klassieke extractie-analyse van weefselhomogenaten 
maakt het mogelijk het aandeel van de metabolieten op het verdelings­
patroon te leren kennen. 
In hoofdstuk 4 is voor meprobamaat, carisoprodol (Solacen11) en 
tybamaat (Apesan11), en in hoofdstuk 5 voor diazepam (Valium14) en 
chloordiazepoxide (Librium1 1) de kinetiek van verdeling en metabolisme 
bij muizen weergegeven. Met behulp van de macroautoradiografie zijn 
verdelingspatronen verkregen na verschillende tijden en wijzen van 
toediening. Door toepassing van chromatografische scheidingen en 
stralingsmeting zijn de oorspronkelijke stoffen en de metabolieten kwan­
titatief gevolgd. Fysisch-chemische eigenschappen, b.v. uitgedrukt als 
verdelingscoëfficiënten tussen een organisch oplosmiddel en water, zijn 
in verband gebracht met de graduele verschillen van penetratie in de 
lipofielc delen van het lichaam. Grote lipofiliteit van het geneesmiddel 
blijkt samen te gaan met een snelle penetratie in b.v. de hersenen. 
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Hoofdstuk 6. De individuele verschillen in de farmacokinetiek van de 
bestudeerde ataractica komen sterk naar voren in de experimenten met 
honden. De isotoop-verdunningsanalyse maakt nauwkeurige meting van 
de plasmaconcentratie mogelijk. Biofarmaceutische aspecten zijn be-
sproken. De verbindingen blijken in het algemeen snel omgezet te wor-
den. De gevormde metabolieten bezitten een langere biologische half-
waardetijd dan de oorspronkelijke stof. De fictieve verdelingsvolumina 
van de geneesmiddelen uit de meprobamaat-groep welke berekend 
werden op basis van de plasmawaterconcentratic in een één-comparti-
mentsystcem, blijken grote verschillen te vertonen in overeenstemming 
met de lipofiele eigenschappen. Berekend op basis van de plasmacon-
centratie zijn deze verschillen gering. 
De grote individuele variatie en het gecompliceerde verloop van de 
concentratie, die bij de vertegenwoordigers van de diazepine-groep 
geconstateerd werden, maakten het nog niet mogelijk nauwkeurige 
kinetische berekeningen uit te voeren. De veronderstelling, dat het 
fictieve verdelingsvolume in de praktijk een constante individuele waarde 
heeft, onafhankelijk van de gegeven dosis, moet betwijfeld worden gezien 
de potentiële grootte van dit volume. Nader onderzoek is echter nood-
zakelijk. 
De eiwitbinding van chloordiazepoxide en van diazepam bij de farma-
cologisch werkzame plasmaconcentraties bedraagt resp. ^ 90 % en i 
95 %. De beperkende invloed die de eiwitbinding op de verdeling van 
deze geneesmiddelen zou kunnen hebben wordt grotendeels gecom-
penseerd door de snelle en grote uitwisseling met de lipofiele weefsels 
van het lichaam. Gegevens verkregen bij de hond vormden de inleiding 
tot de analyse van diazepam bij de mens met behulp van gaschromato-
grafie. 
Hoofdstuk 7. Bij de mens worden in tegenstelling tot bij de muis en de 
hond veel langere biologische half-waardetijdcn van diazepam gecon-
stateerd. Daar deze lange t^ aanleiding kan zijn tot cumulatie, zijn de 
plasmaconcentraties over lange periodes gevolgd. Na ongeveer 4 dagen 
wordt een cumulatieplateau bereikt. Grote individuele variaties en grillig 
verloop van de concentratie, waarschijnlijk als gevolg van entérale 
processen, zijn geconstateerd. N-desmethyldiazepam wordt als de 
belangrijkste metaboliet in plasma aangetroffen en heeft eveneens de 
neiging tot cumuleren bij chronisch gebruik. De concentratie aan metabo-
liet stijgt tot ongeveer gelijke hoogte als diazepam. Een gaschromato-
grafische analyse methode in biologisch milieu van een aantal diazepines 
is beschreven. 
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S T E L L I N G E N 
ι. Bij de bepaling van diazepam in plasma wordt door DE SILVA en 
medewerkers ten onrechte verondersteld dat geen oxydatieproducten 
aanwezig zijn. 
DE SILVA, J. A. F . , SCHWARTZ, Μ. Α., STEVANOVIC, V., K A P L A N , J. en 
D ' A R C O N T E , L . Anal. Chem., 1964, 36, 2099. 
2. H e t maagdarmkanaal draagt voor een belangrijk gedeelte bij aan 
het fictieve verdelingsvolume van psychofarmaca. M e t de depotfunctie 
van het maagdarmkanaal voor deze geneesmiddelen dient rekening 
gehouden te worden bij de behandel ing van overdoseringen en bij de 
potentiëring door o.a. alcohol. 
3. De experimenten van KARE en medewerkers zijn niet bewijzend 
voor een directe t ransportweg tussen de mondhol te en de hersenen. 
a. — KARE, M . R., SCHECHTER, P . J., GROSSMAN, S. P. en R O T H , L . J. 
Science, 1969, 163, 952. 
b. — M A L L E R , О., KARE, M . R., W E L T , M . en BEHRMAN, H. Nature, 
1967, 213, 7*3-
4. D e concentrat ieverhouding in ur ine van oes t rogenen-en 17-hydro-
xycorticosteroïden kan een waardevolle indicatie zijn voor de predispositie 
voor het ontstaan van varicosis. 
ILCA, S., D O D I C A , C. en IOANAVICI, Z. Proc. 3rd Congress on Phle-
bology, Amsterdam, 1968. Noord Nederlandse Uitgeverij, Stenfert, 
Meppel , 1969. 
5. He t is aan twijfel onderhevig of de moleculair gewichtsschattingen 
volgens SHAPIRO en medewerkers in SDS-bevat tende Polyacrylamide gels 
betrekking hebben op polypeptide ketens. 
a. — S H A P I R O , A. L. , VINUELA, E. en M A I Z E L , J. V., Jr. BBRC, 
1967, 28, 815. 
b. — SHAPIRO, A. L. Invest. Ophtalm., 1968, 7, 462. 
6. Table t ten van acetylsalicylzuur met vertraagde afgifte hebben geen 
zin wanneer de verlengde werkzaamheid van dit geneesmiddel beoogd 
wordt. 
a. — W I S E M A N , E. H . en F E D E R I C I , N . J. J. Pharm. Sci., 1968, 57, 
Ι535· 
b. — R O W L A N D , M. en RIEGELMAN, S. J. Pharm. Sci., 1968, 57, 1313. 
7. D e dosis afhankelijke eliminatiesnelheid van het anticoagulans bis-
hydroxycoumarine laat zich niet verklaren met behulp van het farma-
cokinetische model met drie compart imenten zoals toegepast door 
N A G A S H I M A en medewerkers. 
a. — XAGASHIMA, R., LEVY, G. en N E L S O N , E. J. Pharm. Sci., 1968, 
57, 58. 
b. — NAGASHIMA, R., LEVY, G. en O ' R E I L L Y , R. A. idem, 1968, 57, 
1888. 
8. I n de magistrale receptuur wordt onvoldoende aandacht besteed 
aan de biofarmaceutische aspecten der voorschriften. 
9. Het is niet geoorloofd de dosering van sterk lipofiele geneesmidde­
len vast te stellen op basis van leeftijd, l ichaamsgewicht of l ichaams­
oppervlak. 
10. O m de toepassing van nieuwe materialen en technieken in de beel­
d e n d e kunst mogelijk te maken dient ruimere materiële en financiële 
steun beschikbaar gesteld te worden. 
E. VAN DER K L E I J N 1 juli 1969 

